false 2023 Q2 0000707549 June 25 P6M P2Y 0000707549 2022-06-27 2022-12-25 0000707549 2023-01-26 xbrli:shares 0000707549 2022-09-26 2022-12-25 iso4217:USD 0000707549 2021-09-27 2021-12-26 0000707549 2021-06-28 2021-12-26 iso4217:USD xbrli:shares 0000707549 2022-12-25 0000707549 2022-06-26 0000707549 2021-06-27 0000707549 2021-12-26 0000707549 us-gaap:CommonStockMember 2022-09-25 0000707549 us-gaap:AdditionalPaidInCapitalMember 2022-09-25 0000707549 us-gaap:TreasuryStockCommonMember 2022-09-25 0000707549 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-25 0000707549 us-gaap:RetainedEarningsMember 2022-09-25 0000707549 2022-09-25 0000707549 us-gaap:CommonStockMember 2022-09-26 2022-12-25 0000707549 us-gaap:AdditionalPaidInCapitalMember 2022-09-26 2022-12-25 0000707549 us-gaap:TreasuryStockCommonMember 2022-09-26 2022-12-25 0000707549 us-gaap:RetainedEarningsMember 2022-09-26 2022-12-25 0000707549 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-26 2022-12-25 0000707549 us-gaap:CommonStockMember 2022-12-25 0000707549 us-gaap:AdditionalPaidInCapitalMember 2022-12-25 0000707549 us-gaap:TreasuryStockCommonMember 2022-12-25 0000707549 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-25 0000707549 us-gaap:RetainedEarningsMember 2022-12-25 0000707549 us-gaap:CommonStockMember 2022-06-26 0000707549 us-gaap:AdditionalPaidInCapitalMember 2022-06-26 0000707549 us-gaap:TreasuryStockCommonMember 2022-06-26 0000707549 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-26 0000707549 us-gaap:RetainedEarningsMember 2022-06-26 0000707549 us-gaap:CommonStockMember 2022-06-27 2022-12-25 0000707549 us-gaap:AdditionalPaidInCapitalMember 2022-06-27 2022-12-25 0000707549 us-gaap:TreasuryStockCommonMember 2022-06-27 2022-12-25 0000707549 us-gaap:RetainedEarningsMember 2022-06-27 2022-12-25 0000707549 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-27 2022-12-25 0000707549 us-gaap:CommonStockMember 2021-09-26 0000707549 us-gaap:AdditionalPaidInCapitalMember 2021-09-26 0000707549 us-gaap:TreasuryStockCommonMember 2021-09-26 0000707549 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-26 0000707549 us-gaap:RetainedEarningsMember 2021-09-26 0000707549 2021-09-26 0000707549 us-gaap:CommonStockMember 2021-09-27 2021-12-26 0000707549 us-gaap:AdditionalPaidInCapitalMember 2021-09-27 2021-12-26 0000707549 us-gaap:TreasuryStockCommonMember 2021-09-27 2021-12-26 0000707549 us-gaap:RetainedEarningsMember 2021-09-27 2021-12-26 0000707549 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-27 2021-12-26 0000707549 us-gaap:CommonStockMember 2021-12-26 0000707549 us-gaap:AdditionalPaidInCapitalMember 2021-12-26 0000707549 us-gaap:TreasuryStockCommonMember 2021-12-26 0000707549 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-26 0000707549 us-gaap:RetainedEarningsMember 2021-12-26 0000707549 us-gaap:CommonStockMember 2021-06-27 0000707549 us-gaap:AdditionalPaidInCapitalMember 2021-06-27 0000707549 us-gaap:TreasuryStockCommonMember 2021-06-27 0000707549 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-27 0000707549 us-gaap:RetainedEarningsMember 2021-06-27 0000707549 us-gaap:CommonStockMember 2021-06-28 2021-12-26 0000707549 us-gaap:AdditionalPaidInCapitalMember 2021-06-28 2021-12-26 0000707549 us-gaap:TreasuryStockCommonMember 2021-06-28 2021-12-26 0000707549 us-gaap:RetainedEarningsMember 2021-06-28 2021-12-26 0000707549 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-28 2021-12-26 0000707549 2022-12-26 2022-12-25 0000707549 2023-12-25 2022-12-25 0000707549 2025-12-29 2022-12-25 lrcx:segment lrcx:region lrcx:primary_market 0000707549 lrcx:SystemMember 2022-09-26 2022-12-25 0000707549 lrcx:SystemMember 2021-09-27 2021-12-26 0000707549 lrcx:SystemMember 2022-06-27 2022-12-25 0000707549 lrcx:SystemMember 2021-06-28 2021-12-26 0000707549 lrcx:CustomerSupportandOtherMember 2022-09-26 2022-12-25 0000707549 lrcx:CustomerSupportandOtherMember 2021-09-27 2021-12-26 0000707549 lrcx:CustomerSupportandOtherMember 2022-06-27 2022-12-25 0000707549 lrcx:CustomerSupportandOtherMember 2021-06-28 2021-12-26 0000707549 country:CN 2022-09-26 2022-12-25 0000707549 country:CN 2021-09-27 2021-12-26 0000707549 country:CN 2022-06-27 2022-12-25 0000707549 country:CN 2021-06-28 2021-12-26 0000707549 country:KR 2022-09-26 2022-12-25 0000707549 country:KR 2021-09-27 2021-12-26 0000707549 country:KR 2022-06-27 2022-12-25 0000707549 country:KR 2021-06-28 2021-12-26 0000707549 country:TW 2022-09-26 2022-12-25 0000707549 country:TW 2021-09-27 2021-12-26 0000707549 country:TW 2022-06-27 2022-12-25 0000707549 country:TW 2021-06-28 2021-12-26 0000707549 country:JP 2022-09-26 2022-12-25 0000707549 country:JP 2021-09-27 2021-12-26 0000707549 country:JP 2022-06-27 2022-12-25 0000707549 country:JP 2021-06-28 2021-12-26 0000707549 lrcx:SouthEastAsiaMember 2022-09-26 2022-12-25 0000707549 lrcx:SouthEastAsiaMember 2021-09-27 2021-12-26 0000707549 lrcx:SouthEastAsiaMember 2022-06-27 2022-12-25 0000707549 lrcx:SouthEastAsiaMember 2021-06-28 2021-12-26 0000707549 country:US 2022-09-26 2022-12-25 0000707549 country:US 2021-09-27 2021-12-26 0000707549 country:US 2022-06-27 2022-12-25 0000707549 country:US 2021-06-28 2021-12-26 0000707549 srt:EuropeMember 2022-09-26 2022-12-25 0000707549 srt:EuropeMember 2021-09-27 2021-12-26 0000707549 srt:EuropeMember 2022-06-27 2022-12-25 0000707549 srt:EuropeMember 2021-06-28 2021-12-26 0000707549 us-gaap:ProductConcentrationRiskMember lrcx:MemoryMember us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember 2022-09-26 2022-12-25 xbrli:pure 0000707549 us-gaap:ProductConcentrationRiskMember lrcx:MemoryMember us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember 2021-09-27 2021-12-26 0000707549 us-gaap:ProductConcentrationRiskMember lrcx:MemoryMember us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember 2022-06-27 2022-12-25 0000707549 us-gaap:ProductConcentrationRiskMember lrcx:MemoryMember us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember 2021-06-28 2021-12-26 0000707549 lrcx:FoundryMember us-gaap:ProductConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember 2022-09-26 2022-12-25 0000707549 lrcx:FoundryMember us-gaap:ProductConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember 2021-09-27 2021-12-26 0000707549 lrcx:FoundryMember us-gaap:ProductConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember 2022-06-27 2022-12-25 0000707549 lrcx:FoundryMember us-gaap:ProductConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember 2021-06-28 2021-12-26 0000707549 us-gaap:ProductConcentrationRiskMember lrcx:LogicIntegratedDeviceManufacturingMember us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember 2022-09-26 2022-12-25 0000707549 us-gaap:ProductConcentrationRiskMember lrcx:LogicIntegratedDeviceManufacturingMember us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember 2021-09-27 2021-12-26 0000707549 us-gaap:ProductConcentrationRiskMember lrcx:LogicIntegratedDeviceManufacturingMember us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember 2022-06-27 2022-12-25 0000707549 us-gaap:ProductConcentrationRiskMember lrcx:LogicIntegratedDeviceManufacturingMember us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember 2021-06-28 2021-12-26 0000707549 lrcx:PubliclyTradedCompanyMember us-gaap:EquitySecuritiesMember 2021-06-28 2021-12-26 0000707549 lrcx:PubliclyTradedCompanyMember us-gaap:EquitySecuritiesMember 2021-09-27 2021-12-26 0000707549 us-gaap:TaxYear2018Member 2022-06-27 2022-09-25 0000707549 lrcx:TaxExaminationsOrLapsesOfStatuteOfLimitationMember 2022-12-25 0000707549 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:EquitySecuritiesMember 2022-12-25 0000707549 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:EquitySecuritiesMember 2022-06-26 0000707549 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-25 0000707549 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2022-12-25 0000707549 us-gaap:MutualFundMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-25 0000707549 us-gaap:MutualFundMember us-gaap:FairValueInputsLevel1Member 2022-12-25 0000707549 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-25 0000707549 us-gaap:FairValueInputsLevel1Member 2022-12-25 0000707549 us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-25 0000707549 us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember 2022-12-25 0000707549 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-25 0000707549 us-gaap:FairValueInputsLevel2Member 2022-12-25 0000707549 us-gaap:FairValueMeasurementsRecurringMember 2022-12-25 0000707549 us-gaap:CashMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-25 0000707549 us-gaap:CashMember 2022-12-25 0000707549 us-gaap:BankTimeDepositsMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-25 0000707549 us-gaap:BankTimeDepositsMember 2022-12-25 0000707549 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-26 0000707549 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2022-06-26 0000707549 us-gaap:MutualFundMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-26 0000707549 us-gaap:MutualFundMember us-gaap:FairValueInputsLevel1Member 2022-06-26 0000707549 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-26 0000707549 us-gaap:FairValueInputsLevel1Member 2022-06-26 0000707549 us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2022-06-26 0000707549 us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember 2022-06-26 0000707549 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-26 0000707549 us-gaap:FairValueInputsLevel2Member 2022-06-26 0000707549 us-gaap:FairValueMeasurementsRecurringMember 2022-06-26 0000707549 us-gaap:CashMember us-gaap:FairValueMeasurementsRecurringMember 2022-06-26 0000707549 us-gaap:CashMember 2022-06-26 0000707549 us-gaap:BankTimeDepositsMember us-gaap:FairValueMeasurementsRecurringMember 2022-06-26 0000707549 us-gaap:BankTimeDepositsMember 2022-06-26 0000707549 us-gaap:MutualFundMember 2022-12-25 0000707549 us-gaap:CorporateDebtSecuritiesMember 2022-12-25 0000707549 us-gaap:CustomerRelationshipsMember 2022-12-25 0000707549 us-gaap:CustomerRelationshipsMember 2022-06-26 0000707549 lrcx:ExistingTechnologyMember 2022-12-25 0000707549 lrcx:ExistingTechnologyMember 2022-06-26 0000707549 us-gaap:PatentsMember 2022-12-25 0000707549 us-gaap:PatentsMember 2022-06-26 0000707549 us-gaap:InProcessResearchAndDevelopmentMember 2022-12-25 0000707549 us-gaap:InProcessResearchAndDevelopmentMember 2022-06-26 0000707549 lrcx:SecuredOvernightFinancingRateSOFRAdministratorPlusMember us-gaap:RevolvingCreditFacilityMember 2022-12-07 2022-12-07 0000707549 lrcx:FederalFundsRateMember us-gaap:RevolvingCreditFacilityMember 2022-12-07 2022-12-07 0000707549 lrcx:SecuredOvernightFinancingRateSOFRMember us-gaap:RevolvingCreditFacilityMember 2022-12-07 2022-12-07 0000707549 lrcx:VariableRateComponentOneMember srt:MinimumMember lrcx:SecuredOvernightFinancingRateSOFRMember us-gaap:RevolvingCreditFacilityMember 2022-12-07 2022-12-07 0000707549 lrcx:VariableRateComponentOneMember lrcx:SecuredOvernightFinancingRateSOFRMember srt:MaximumMember us-gaap:RevolvingCreditFacilityMember 2022-12-07 2022-12-07 0000707549 lrcx:VariableRateComponentTwoMember srt:MinimumMember lrcx:SecuredOvernightFinancingRateSOFRMember us-gaap:RevolvingCreditFacilityMember 2022-12-07 2022-12-07 0000707549 lrcx:VariableRateComponentTwoMember lrcx:SecuredOvernightFinancingRateSOFRMember srt:MaximumMember us-gaap:RevolvingCreditFacilityMember 2022-12-07 2022-12-07 0000707549 us-gaap:RevolvingCreditFacilityMember 2022-12-25 0000707549 lrcx:FinanceLeaseCashCollateralMember 2022-12-25 0000707549 lrcx:FremontAndLivermoreLeaseMember 2022-12-25 0000707549 lrcx:FremontAndLivermoreLeaseMember 2022-12-25 0000707549 us-gaap:StandbyLettersOfCreditMember 2022-12-25 0000707549 us-gaap:OtherNoncurrentLiabilitiesMember 2022-12-25 0000707549 lrcx:StockRepurchaseProgramMember 2022-05-01 2022-05-31 0000707549 lrcx:StockRepurchaseProgramMember 2022-06-26 0000707549 lrcx:StockRepurchaseProgramMember 2022-06-27 2022-09-25 0000707549 lrcx:StockRepurchaseProgramMember 2022-09-25 0000707549 lrcx:StockRepurchaseProgramMember 2022-09-26 2022-12-25 0000707549 lrcx:StockRepurchaseProgramMember 2022-12-25 0000707549 lrcx:June2022AcceleratedShareRepurchaseAgreementMember 2022-06-02 lrcx:financial_institution 0000707549 lrcx:June2022AcceleratedShareRepurchaseAgreementMember 2022-06-02 2022-06-02 0000707549 lrcx:June2022AcceleratedShareRepurchaseAgreementMember 2022-09-01 2022-09-25 0000707549 us-gaap:AccumulatedTranslationAdjustmentMember 2022-06-26 0000707549 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-06-26 0000707549 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2022-06-26 0000707549 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-06-26 0000707549 us-gaap:AccumulatedTranslationAdjustmentMember 2022-06-27 2022-12-25 0000707549 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-06-27 2022-12-25 0000707549 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2022-06-27 2022-12-25 0000707549 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-06-27 2022-12-25 0000707549 us-gaap:AccumulatedTranslationAdjustmentMember 2022-12-25 0000707549 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-12-25 0000707549 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2022-12-25 0000707549 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-12-25 0000707549 lrcx:TwoBusinessCombinationTransactionsMember 2022-11-01 2022-11-30 lrcx:business 0000707549 lrcx:TwoBusinessCombinationTransactionsMember 2022-11-30 0000707549 lrcx:TwoBusinessCombinationTransactionsMember us-gaap:TechnologyBasedIntangibleAssetsMember 2022-11-01 2022-11-30 0000707549 lrcx:TwoBusinessCombinationTransactionsMember us-gaap:TechnologyBasedIntangibleAssetsMember 2022-11-30 0000707549 lrcx:TwoBusinessCombinationTransactionsMember us-gaap:CustomerRelationshipsMember 2022-11-01 2022-11-30 0000707549 lrcx:TwoBusinessCombinationTransactionsMember us-gaap:CustomerRelationshipsMember 2022-11-30 0000707549 lrcx:TwoBusinessCombinationTransactionsMember us-gaap:InProcessResearchAndDevelopmentMember 2022-11-30 0000707549 us-gaap:SubsequentEventMember us-gaap:ScenarioPlanMember 2023-01-01 2023-01-31 lrcx:employee 0000707549 us-gaap:SubsequentEventMember 2023-01-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)

☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended December 25, 2022
or

☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to
Commission file number 0-12933
___________________________________________________________
LAM RESEARCH CORPORATION
(Exact name of registrant as specified in its charter)
___________________________________________________________

Delaware |  | 94-2634797
(State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification No.)

4650 Cushing Parkway, | Fremont, | California |  | 94538

(Address of principal executive offices) |  | (Zip Code)

Registrant’s telephone number, including area code: (510) 572-0200
Securities registered pursuant to Section 12(b) of the Act:

Title of each class | Trading Symbol(s) | Name of each exchange on which registered
Common Stock, Par Value $0.001 Per Share | LRCX | The Nasdaq Stock Market
|  | (Nasdaq Global Select Market)

__________________________________________________
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer |  | ☒ |  | Accelerated filer |  | ☐
Non-accelerated filer |  | ☐ |  | Smaller reporting company |  | ☐
|  |  |  | Emerging growth company |  | ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
As of January 26, 2023, the Registrant had 134,936,209 shares of Common Stock outstanding.

LAM RESEARCH CORPORATION
TABLE OF CONTENTS

|  | Page No.
| PART I. Financial Information |
Item 1. | Financial Statements (Unaudited): |
| Condensed Consolidated Statements of Operations for the three and six months ended December 25, 2022 and December 26, 2021 | 3
| Condensed Consolidated Statements of Comprehensive Income for the three and six months ended December 25, 2022, and December 26, 2021 | 4
| Condensed Consolidated Balance Sheets as of December 25, 2022, and June 26, 2022 | 5
| Condensed Consolidated Statements of Cash Flows for the six months ended December 25, 2022, and December 26, 2021 | 6
| Condensed Consolidated Statements of Stockholders’ Equity for the three and six months ended December 25, 2022, and December 26, 2021 | 7
| Notes to Condensed Consolidated Financial Statements | 9
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 21
Item 3. | Quantitative and Qualitative Disclosures about Market Risk | 27
Item 4. | Controls and Procedures | 27
| PART II. Other Information |
Item 1. | Legal Proceedings | 28
Item 1A. | Risk Factors | 28
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 40
Item 3. | Defaults Upon Senior Securities | 41
Item 4. | Mine Safety Disclosures | 41
Item 5. | Other Information | 41
Item 6. | Exhibits | 42
Signatures | 43

Table of Contents
PART I. FINANCIAL INFORMATION
ITEM 1. Financial Statements
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
(unaudited)

| Three Months Ended |  | Six Months Ended
| December 25, 2022 |  | December 26, 2021 |  | December 25, 2022 |  | December 26, 2021
Revenue | $ | 5,277,569 |  |  | $ | 4,226,604 |  |  | $ | 10,351,690 |  |  | $ | 8,531,069 |
Cost of goods sold | 2,901,220 |  |  | 2,248,688 |  |  | 5,638,506 |  |  | 4,576,399 |
Gross margin | 2,376,349 |  |  | 1,977,916 |  |  | 4,713,184 |  |  | 3,954,670 |
Research and development | 462,385 |  |  | 403,644 |  |  | 895,760 |  |  | 785,971 |
Selling, general, and administrative | 233,802 |  |  | 236,133 |  |  | 439,422 |  |  | 458,327 |
Total operating expenses | 696,187 |  |  | 639,777 |  |  | 1,335,182 |  |  | 1,244,298 |
Operating income | 1,680,162 |  |  | 1,338,139 |  |  | 3,378,002 |  |  | 2,710,372 |
Other income (expense), net | (28,234) |  |  | 17,999 |  |  | (71,329) |  |  | (10,858) |
Income before income taxes | 1,651,928 |  |  | 1,356,138 |  |  | 3,306,673 |  |  | 2,699,514 |
Income tax expense | (183,421) |  |  | (161,308) |  |  | (412,287) |  |  | (324,940) |
Net income | $ | 1,468,507 |  |  | $ | 1,194,830 |  |  | $ | 2,894,386 |  |  | $ | 2,374,574 |
Net income per share: |  |  |  |  |  |  |
Basic | $ | 10.80 |  |  | $ | 8.50 |  |  | $ | 21.21 |  |  | $ | 16.82 |
Diluted | $ | 10.77 |  |  | $ | 8.44 |  |  | $ | 21.16 |  |  | $ | 16.71 |
Number of shares used in per share calculations: |  |  |  |  |  |  |
Basic | 136,018 |  |  | 140,630 |  |  | 136,455 |  |  | 141,187 |
Diluted | 136,339 |  |  | 141,530 |  |  | 136,774 |  |  | 142,071 |

See Notes to Condensed Consolidated Financial Statements
Lam Research Corporation 2023 Q2 10-Q 3

Table of Contents
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(in thousands)
(unaudited)

| Three Months Ended |  | Six Months Ended
| December 25, 2022 |  | December 26, 2021 |  | December 25, 2022 |  | December 26, 2021
Net income | $ | 1,468,507 |  |  | $ | 1,194,830 |  |  | $ | 2,894,386 |  |  | $ | 2,374,574 |
Other comprehensive income (loss), net of tax: |  |  |  |  |  |  |
Foreign currency translation adjustment | 41,470 |  |  | (9,820) |  |  | 7,861 |  |  | (13,852) |
Cash flow hedges: |  |  |  |  |  |  |
Net unrealized (losses) gains during the period | (18,618) |  |  | 12,792 |  |  | 185 |  |  | 3,787 |
Net losses (gains) reclassified into net income | 1,273 |  |  | (7,904) |  |  | (8,024) |  |  | (11,446) |
| (17,345) |  |  | 4,888 |  |  | (7,839) |  |  | (7,659) |
Available-for-sale investments: |  |  |  |  |  |  |
Net unrealized gains (losses) during the period | 490 |  |  | (785) |  |  | 570 |  |  | (3,190) |
Net losses (gains) reclassified into net income | — |  |  | 345 |  |  | (53) |  |  | 1,490 |
| 490 |  |  | (440) |  |  | 517 |  |  | (1,700) |
Defined benefit plans, net change in unrealized component | 279 |  |  | (1,006) |  |  | 572 |  |  | (807) |
Other comprehensive income (loss), net of tax | 24,894 |  |  | (6,378) |  |  | 1,111 |  |  | (24,018) |
Comprehensive income | $ | 1,493,401 |  |  | $ | 1,188,452 |  |  | $ | 2,895,497 |  |  | $ | 2,350,556 |

See Notes to Condensed Consolidated Financial Statements
Lam Research Corporation 2023 Q2 10-Q 4

Table of Contents
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except per share data)

| December 25, 2022 |  | June 26, 2022
| (unaudited) |  | (1)
ASSETS |  |  |
Cash and cash equivalents | $ | 4,484,716 |  |  | $ | 3,522,001 |
Investments | 103,130 |  |  | 135,731 |
Accounts receivable, less allowance of $5,411 as of December 25, 2022, and $5,606 as of June 26, 2022 | 4,070,088 |  |  | 4,313,818 |
Inventories | 4,819,966 |  |  | 3,966,294 |
Prepaid expenses and other current assets | 230,888 |  |  | 347,391 |
Total current assets | 13,708,788 |  |  | 12,285,235 |
Property and equipment, net | 1,863,155 |  |  | 1,647,587 |
Restricted cash and investments | 251,344 |  |  | 251,534 |
Goodwill | 1,620,437 |  |  | 1,515,113 |
Intangible assets, net | 184,781 |  |  | 101,850 |
Other assets | 1,577,876 |  |  | 1,394,313 |
Total assets | $ | 19,206,381 |  |  | $ | 17,195,632 |
LIABILITIES AND STOCKHOLDERS’ EQUITY |  |  |
Trade accounts payable | $ | 919,408 |  |  | $ | 1,011,208 |
Accrued expenses and other current liabilities | 2,068,370 |  |  | 1,974,272 |
Deferred profit | 1,551,918 |  |  | 1,571,898 |
Current portion of long-term debt and finance lease obligations | 7,226 |  |  | 7,381 |
Total current liabilities | 4,546,922 |  |  | 4,564,759 |
Long-term debt and finance lease obligations, less current portion | 4,996,057 |  |  | 4,998,449 |
Income taxes payable | 862,405 |  |  | 931,117 |
Other long-term liabilities | 496,362 |  |  | 422,941 |
Total liabilities | 10,901,746 |  |  | 10,917,266 |
Commitments and contingencies |  |  |
Stockholders’ equity: |  |  |
Preferred stock, at par value of $0.001 per share; authorized, 5,000 shares, none outstanding | — |  |  | — |
Common stock, at par value of $0.001 per share; authorized, 400,000 shares as of December 25, 2022 and June 26, 2022; issued and outstanding, 135,403 shares as of December 25, 2022, and 136,975 shares as of June 26, 2022 | 135 |  |  | 137 |
Additional paid-in capital | 7,606,149 |  |  | 7,414,916 |
Treasury stock, at cost; 158,775 shares as of December 25, 2022, and 157,087 shares as of June 26, 2022 | (20,071,931) |  |  | (19,481,429) |
Accumulated other comprehensive loss | (108,871) |  |  | (109,982) |
Retained earnings | 20,879,153 |  |  | 18,454,724 |
Total stockholders’ equity | 8,304,635 |  |  | 6,278,366 |
Total liabilities and stockholders’ equity | $ | 19,206,381 |  |  | $ | 17,195,632 |

(1)Derived from audited financial statements
See Notes to Condensed Consolidated Financial Statements
Lam Research Corporation 2023 Q2 10-Q 5

Table of Contents
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands) (unaudited)

| Six Months Ended
| December 25, 2022 |  | December 26, 2021
CASH FLOWS FROM OPERATING ACTIVITIES: |  |  |
Net income | $ | 2,894,386 |  |  | $ | 2,374,574 |
Adjustments to reconcile net income to net cash provided by operating activities: |  |  |
Depreciation and amortization | 161,165 |  |  | 161,579 |
Deferred income taxes | (140,296) |  |  | (26,573) |
Equity-based compensation expense | 144,194 |  |  | 120,933 |
Other, net | 9,978 |  |  | (75,204) |
Changes in operating assets and liabilities | (739,652) |  |  | (657,279) |
Net cash provided by operating activities | 2,329,775 |  |  | 1,898,030 |
CASH FLOWS FROM INVESTING ACTIVITIES: |  |  |
Capital expenditures and intangible assets | (303,441) |  |  | (274,920) |
Business acquisitions, net of cash acquired | (119,955) |  |  | — |
Purchases of available-for-sale securities | — |  |  | (268,457) |
Proceeds from maturities of available-for-sales securities | 32,438 |  |  | 134,096 |
Proceeds from sales of available-for-sale securities | — |  |  | 1,197,575 |
Other, net | (4,092) |  |  | (5,518) |
Net cash (used for) provided by investing activities | (395,050) |  |  | 782,776 |
CASH FLOWS FROM FINANCING ACTIVITIES: |  |  |
Principal payments on debt | (18,936) |  |  | (8,036) |
Treasury stock purchases | (566,055) |  |  | (1,651,568) |
Dividends paid | (441,595) |  |  | (396,647) |
Reissuance of treasury stock related to employee stock purchase plan | 44,996 |  |  | 46,380 |
Proceeds from issuance of common stock | 7,673 |  |  | 4,193 |
Other, net | 764 |  |  | (17) |
Net cash used for financing activities | (973,153) |  |  | (2,005,695) |
Effect of exchange rate changes on cash, cash equivalents, and restricted cash | 953 |  |  | (8,454) |
Net increase in cash, cash equivalents, and restricted cash | 962,525 |  |  | 666,657 |
Cash, cash equivalents, and restricted cash at beginning of period | 3,773,535 |  |  | 4,670,750 |
Cash, cash equivalents, and restricted cash at end of period | $ | 4,736,060 |  |  | $ | 5,337,407 |
Schedule of non-cash transactions: |  |  |
Accrued payables for stock repurchases | $ | 30,125 |  |  | $ | 20,103 |
Accrued payables for capital expenditures | 94,494 |  |  | 96,425 |
Dividends payable | 233,977 |  |  | 210,587 |
Transfers of finished goods inventory to property and equipment | 56,932 |  |  | 55,322 |
Reconciliation of cash, cash equivalents, and restricted cash | December 25, 2022 |  | December 26, 2021
Cash and cash equivalents | $ | 4,484,716 |  |  | $ | 5,086,544 |
Restricted cash and cash equivalents | 251,344 |  |  | 250,863 |
Total cash, cash equivalents, and restricted cash | $ | 4,736,060 |  |  | $ | 5,337,407 |

See Notes to Condensed Consolidated Financial Statements
Lam Research Corporation 2023 Q2 10-Q 6

Table of Contents
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(in thousands)
(unaudited)

| Three Months Ended
| December 25, 2022
| Common Stock Shares |  | Common Stock |  | Additional Paid-in Capital |  | Treasury Stock |  | Accumulated Other Comprehensive Loss |  | Retained Earnings |  | Total
Balance at September 25, 2022 | 136,374 |  |  | $ | 136 |  |  | $ | 7,492,822 |  |  | $ | (19,591,249) |  |  | $ | (133,765) |  |  | $ | 19,644,623 |  |  | $ | 7,412,567 |
Issuance of common stock | 31 |  |  | — |  |  | 877 |  |  | — |  |  | — |  |  | — |  |  | 877 |
Purchase of treasury stock | (1,133) |  |  | (1) |  |  | — |  |  | (486,312) |  |  | — |  |  | — |  |  | (486,313) |
Reissuance of treasury stock | 131 |  |  | — |  |  | 39,366 |  |  | 5,630 |  |  | — |  |  | — |  |  | 44,996 |
Equity-based compensation expense | — |  |  | — |  |  | 73,084 |  |  | — |  |  | — |  |  | — |  |  | 73,084 |
Net income | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 1,468,507 |  |  | 1,468,507 |
Other comprehensive income | — |  |  | — |  |  | — |  |  | — |  |  | 24,894 |  |  | — |  |  | 24,894 |
Cash dividends declared ($1.725 per common share) | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (233,977) |  |  | (233,977) |
Balance at December 25, 2022 | 135,403 |  |  | $ | 135 |  |  | $ | 7,606,149 |  |  | $ | (20,071,931) |  |  | $ | (108,871) |  |  | $ | 20,879,153 |  |  | $ | 8,304,635 |
| Six Months Ended
| December 25, 2022
| Common Stock Shares |  | Common Stock |  | Additional Paid-in Capital |  | Treasury Stock |  | Accumulated Other Comprehensive Loss |  | Retained Earnings |  | Total
Balance at June 26, 2022 | 136,975 |  |  | $ | 137 |  |  | $ | 7,414,916 |  |  | $ | (19,481,429) |  |  | $ | (109,982) |  |  | $ | 18,454,724 |  |  | $ | 6,278,366 |
Issuance of common stock | 116 |  |  | — |  |  | 7,673 |  |  | — |  |  | — |  |  | — |  |  | 7,673 |
Purchase of treasury stock | (1,819) |  |  | (2) |  |  | — |  |  | (596,132) |  |  | — |  |  | — |  |  | (596,134) |
Reissuance of treasury stock | 131 |  |  | — |  |  | 39,366 |  |  | 5,630 |  |  | — |  |  | — |  |  | 44,996 |
Equity-based compensation expense | — |  |  | — |  |  | 144,194 |  |  | — |  |  | — |  |  | — |  |  | 144,194 |
Net income | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 2,894,386 |  |  | 2,894,386 |
Other comprehensive income | — |  |  | — |  |  | — |  |  | — |  |  | 1,111 |  |  | — |  |  | 1,111 |
Cash dividends declared ($3.450 per common share) | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (469,957) |  |  | (469,957) |
Balance at December 25, 2022 | 135,403 |  |  | $ | 135 |  |  | $ | 7,606,149 |  |  | $ | (20,071,931) |  |  | $ | (108,871) |  |  | $ | 20,879,153 |  |  | $ | 8,304,635 |
See Notes to Condensed Consolidated Financial Statements

Lam Research Corporation 2023 Q2 10-Q 7

Table of Contents

| Three Months Ended
| December 26, 2021
| Common Stock Shares |  | Common Stock |  | Additional Paid-in Capital |  | Treasury Stock |  | Accumulated Other Comprehensive Loss |  | Retained Earnings |  | Total
Balance at September 26, 2021 | 140,811 |  |  | $ | 141 |  |  | $ | 7,111,803 |  |  | $ | (16,863,573) |  |  | $ | (81,768) |  |  | $ | 15,653,440 |  |  | $ | 5,820,043 |
Issuance of common stock | 52 |  |  | — |  |  | 3,451 |  |  | — |  |  | — |  |  | — |  |  | 3,451 |
Purchase of treasury stock | (685) |  |  | (1) |  |  | — |  |  | (434,791) |  |  | — |  |  | — |  |  | (434,792) |
Reissuance of treasury stock | 97 |  |  | — |  |  | 42,271 |  |  | 4,109 |  |  | — |  |  | — |  |  | 46,380 |
Equity-based compensation expense | — |  |  | — |  |  | 62,834 |  |  | — |  |  | — |  |  | — |  |  | 62,834 |
Net income | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 1,194,830 |  |  | 1,194,830 |
Other comprehensive loss | — |  |  | — |  |  | — |  |  | — |  |  | (6,378) |  |  | — |  |  | (6,378) |
Cash dividends declared ($1.50 per common share) | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (210,587) |  |  | (210,587) |
Balance at December 26, 2021 | 140,275 |  |  | $ | 140 |  |  | $ | 7,220,359 |  |  | $ | (17,294,255) |  |  | $ | (88,146) |  |  | $ | 16,637,683 |  |  | $ | 6,475,781 |
| Six Months Ended
| December 26, 2021
| Common Stock Shares |  | Common Stock |  | Additional Paid-in Capital |  | Treasury Stock |  | Accumulated Other Comprehensive Loss |  | Retained Earnings |  | Total
Balance at June 27, 2021 | 142,501 |  |  | $ | 143 |  |  | $ | 7,052,962 |  |  | $ | (15,646,701) |  |  | $ | (64,128) |  |  | $ | 14,684,912 |  |  | $ | 6,027,188 |
Issuance of common stock | 99 |  |  | — |  |  | 4,193 |  |  | — |  |  | — |  |  | — |  |  | 4,193 |
Purchase of treasury stock | (2,422) |  |  | (3) |  |  | — |  |  | (1,651,663) |  |  | — |  |  | — |  |  | (1,651,666) |
Reissuance of treasury stock | 97 |  |  | — |  |  | 42,271 |  |  | 4,109 |  |  | — |  |  | — |  |  | 46,380 |
Equity-based compensation expense | — |  |  | — |  |  | 120,933 |  |  | — |  |  | — |  |  | — |  |  | 120,933 |
Net income | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 2,374,574 |  |  | 2,374,574 |
Other comprehensive loss | — |  |  | — |  |  | — |  |  | — |  |  | (24,018) |  |  | — |  |  | (24,018) |
Cash dividends declared ($3.00 per common share) | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (421,803) |  |  | (421,803) |
Balance at December 26, 2021 | 140,275 |  |  | $ | 140 |  |  | $ | 7,220,359 |  |  | $ | (17,294,255) |  |  | $ | (88,146) |  |  | $ | 16,637,683 |  |  | $ | 6,475,781 |

See Notes to Condensed Consolidated Financial Statements
Lam Research Corporation 2023 Q2 10-Q 8

Table of Contents
LAM RESEARCH CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
December 25, 2022
(Unaudited)
NOTE 1 — BASIS OF PRESENTATION
The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and the instructions to Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation have been included. The accompanying unaudited Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements of Lam Research Corporation (“Lam Research” or the “Company”) for the fiscal year ended June 26, 2022, which are included in the Company’s Annual Report on Form 10-K as of and for the year ended June 26, 2022 (the “2022 Form 10-K”). The Company’s reports on Form 10-K, Form 10-Q and Form 8-K are available online at the Securities and Exchange Commission website on the Internet. The address of that site is www.sec.gov. The Company also posts its reports on Form 10-K, Form 10-Q and Form 8-K on its corporate website at https://investor.lamresearch.com. The content on any website referred to in this Form 10-Q is not a part of or incorporated by reference in this Form 10-Q unless expressly noted.
The condensed consolidated financial statements include the accounts of Lam Research and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. The Company’s reporting period is a 52/53-week fiscal year. The Company’s current fiscal year will end June 25, 2023 and includes 52 weeks. The quarters ended December 25, 2022 (the “December 2022 quarter”) and December 26, 2021 included 13 weeks.
NOTE 2 — RECENT ACCOUNTING PRONOUNCEMENTS
Recently Adopted or Effective
In March 2020, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The ASU provides temporary optional expedients and exceptions for applying generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference the London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued. In January 2021, the FASB issued ASU 2021-01, “ Reference Rate Reform (Topic 848),” which permits entities to apply optional expedients in Topic 848 to derivative instruments modified because of discounting transition resulting from reference rate reform. In December 2022, the FASB issued ASU 2022-06, “Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848,” extending the relief offered in this series of ASUs through December 31, 2024.
In December 2022, the Company executed Amendment No. 1 To Second Amended and Restated Credit Agreement, the primary purpose of which was to change the reference rate for borrowings under the Credit Agreement by replacing LIBOR with the Secured Overnight Financing Rate (“SOFR”). The Company applied practical expedients provided in Topic 848 allowing for the changes in contractual terms to be accounted for prospectively. These modifications had no significant impact on our financial statements. Refer to Note 12 - Long-term debt and other borrowings for further information regarding the terms of the Credit Agreement.
In October 2021, the FASB issued ASU No. 2021-08, “Business Combinations (Topic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers,” which requires contract assets and contract liabilities (e.g., deferred revenue) acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, “Revenue from Contracts with Customers” as if the acquirer had originated the contracts. The guidance is applied prospectively to acquisitions occurring on or after the effective date. The Company early adopted ASU No. 2021-08 during the quarter ended December 25, 2022. The adoption of the new standard did not have a material impact on the Company’s Condensed Consolidated financial statements.
Updates Not Yet Effective
There are no new accounting pronouncements not yet adopted or effective that are expected to have a material impact on the Company’s Condensed Consolidated Financial Statements.
Lam Research Corporation 2023 Q2 10-Q 9

Table of Contents
NOTE 3 — REVENUE
Deferred Revenue
Revenue of $190.2 million and $1,732.7 million included in deferred profit at June 26, 2022 was recognized during the three and six months ended December 25, 2022, respectively.
The following table summarizes the transaction price for contracts that have not yet been recognized as revenue as of December 25, 2022 and when the Company expects to recognize the amounts as revenue:

| Less than 1 Year |  | 1-3 Years |  | More than 3 Years |  | Total
| (In thousands)
Deferred revenue | $ | 1,753,188 |  |  | $ | 228,288 |  | (1) | $ | 2,557 |  | (1) | $ | 1,984,033 |

(1)This amount is reported in Deferred profit on the Company's Condensed Consolidated Balance Sheets as the customers can demand the liability to be performed at any time.
Disaggregation of Revenue
The Company operates in one reportable business segment: manufacturing and servicing of wafer processing semiconductor manufacturing equipment. The Company’s material operating segments qualify for aggregation due to their customer base and similarities in economic characteristics, nature of products and services, and processes for procurement, manufacturing, and distribution.
The Company operates in seven geographic regions: United States, China, Europe, Japan, Korea, Southeast Asia, and Taiwan. For geographical reporting, revenue is attributed to the geographic location in which the customers’ facilities are located. The Company serves three primary markets: memory, foundry, and logic/integrated device manufacturing.
The following table presents the Company’s revenues disaggregated between system and its customer support-related revenue:

| Three Months Ended |  | Six Months Ended
| December 25, 2022 |  | December 26, 2021 |  | December 25, 2022 |  | December 26, 2021
| (In thousands)
System revenue | $ | 3,547,518 |  |  | $ | 2,740,173 |  |  | $ | 6,729,505 |  |  | $ | 5,665,056 |
Customer support-related revenue and other | 1,730,051 |  |  | 1,486,431 |  |  | 3,622,185 |  |  | 2,866,013 |
| $ | 5,277,569 |  |  | $ | 4,226,604 |  |  | $ | 10,351,690 |  |  | $ | 8,531,069 |

System revenue includes sales of new leading-edge equipment in deposition, etch and clean markets.
Customer support-related revenue includes sales of customer service, spares, upgrades, and non-leading-edge equipment from the Company’s Reliant product line.
The following table presents the Company’s revenues disaggregated by geographic region:

| Three Months Ended |  | Six Months Ended
December 25, 2022 |  | December 26, 2021 |  | December 25, 2022 |  | December 26, 2021
| (In thousands)
China | $ | 1,263,507 |  |  | $ | 1,080,973 |  |  | $ | 2,793,982 |  |  | $ | 2,688,683 |
Korea | 1,077,052 |  |  | 1,068,220 |  |  | 1,932,430 |  |  | 1,986,357 |
Taiwan | 991,173 |  |  | 773,121 |  |  | 2,112,119 |  |  | 1,411,187 |
Japan | 575,945 |  |  | 513,936 |  |  | 1,034,638 |  |  | 982,667 |
Southeast Asia | 528,836 |  |  | 364,382 |  |  | 1,069,900 |  |  | 729,630 |
United States | 503,238 |  |  | 244,798 |  |  | 808,215 |  |  | 473,009 |
Europe | 337,818 |  |  | 181,174 |  |  | 600,406 |  |  | 259,536 |
| $ | 5,277,569 |  |  | $ | 4,226,604 |  |  | $ | 10,351,690 |  |  | $ | 8,531,069 |

Lam Research Corporation 2023 Q2 10-Q 10

Table of Contents
The following table presents the percentages of leading- and non-leading-edge equipment and upgrade revenue to each of the primary markets the Company serves:

| Three Months Ended |  | Six Months Ended
| December 25, 2022 |  | December 26, 2021 |  | December 25, 2022 |  | December 26, 2021
Memory | 50 | % |  | 58 | % |  | 50 | % |  | 61 | %
Foundry | 31 | % |  | 31 | % |  | 33 | % |  | 28 | %
Logic/integrated device manufacturing | 19 | % |  | 11 | % |  | 17 | % |  | 11 | %

NOTE 4 — EQUITY-BASED COMPENSATION PLANS
The Lam Research Corporation 2015 Stock Incentive Plan, as amended, provides for the grant of non-qualified equity-based awards of the Company’s Common Stock to eligible employees and non-employee directors, including stock options, restricted stock units (“RSUs”), and market-based performance RSUs (“market-based PRSUs”). An option is a right to purchase Common Stock at a set price. An RSU award is an agreement to issue a set number of shares of Common Stock at the time of vesting. The Company’s market-based PRSUs contain both a market condition and a service condition. The Company’s option, RSU, and market-based PRSU awards typically vest over a period of three years. The Company also has an employee stock purchase plan that allows employees to purchase its Common Stock at a discount through payroll deductions.
The Company recognized the following equity-based compensation expense (including expense related to the employee stock purchase plan) and related income tax benefit in the Condensed Consolidated Statements of Operations:

| Three Months Ended |  | Six Months Ended
| December 25, 2022 |  | December 26, 2021 |  | December 25, 2022 |  | December 26, 2021
| (in thousands)
Equity-based compensation expense | $ | 73,084 |  |  | $ | 62,834 |  |  | $ | 144,194 |  |  | $ | 120,933 |
Income tax benefit recognized related to equity-based compensation expense | $ | 8,676 |  |  | $ | 9,014 |  |  | $ | 20,204 |  |  | $ | 17,222 |

NOTE 5 — OTHER INCOME (EXPENSE), NET
The significant components of other income (expense), net, are as follows:

| Three Months Ended |  | Six Months Ended
| December 25, 2022 |  | December 26, 2021 |  | December 25, 2022 |  | December 26, 2021
| (in thousands)
Interest income | $ | 26,125 |  |  | $ | 2,372 |  |  | $ | 41,181 |  |  | $ | 7,050 |
Interest expense | (46,661) |  |  | (46,765) |  |  | (92,713) |  |  | (91,821) |
Gains (losses) on deferred compensation plan-related assets, net | 10,871 |  |  | (56) |  |  | (1,855) |  |  | 7,381 |
Foreign exchange (losses) gains, net | (10,114) |  |  | 731 |  |  | (3,293) |  |  | 714 |
Other, net | (8,455) |  |  | 61,717 |  |  | (14,649) |  |  | 65,818 |
| $ | (28,234) |  |  | $ | 17,999 |  |  | $ | (71,329) |  |  | $ | (10,858) |

Other, net includes an unrealized gain totaling $46.6 million associated with an equity investee that became publicly traded during the three and six months ended December 26, 2021. Refer to Note 8 - Financial Instruments for additional information regarding the Company’s investments.
Lam Research Corporation 2023 Q2 10-Q 11

Table of Contents
NOTE 6 — INCOME TAX EXPENSE
The Company’s provision for income taxes and effective tax rate are as follows:

| Three Months Ended |  | Six Months Ended
| December 25, 2022 |  | December 26, 2021 |  | December 25, 2022 |  | December 26, 2021
| (in thousands, except percentages)
Income tax expense | $ | 183,421 |  |  | $ | 161,308 |  |  | $ | 412,287 |  |  | $ | 324,940 |
Effective tax rate | 11.1 | % |  | 11.9 | % |  | 12.5 | % |  | 12.0 | %

The difference between the U.S. federal statutory tax rate of 21% and the Company’s effective tax rate for the three and six months ended December 25, 2022 and December 26, 2021 was primarily due to income in lower tax jurisdictions.
The Internal Revenue Service (“IRS”) has examined the Company’s U.S. federal income tax return for the fiscal year ended June 24, 2018. As of September 25, 2022, the IRS has proposed adjustments resulting in a tax liability increase of approximately $50.0 million, which was previously reserved. The Company has agreed to pay the amount and has made a partial cash settlement in the September quarter with the remaining settlement expected to be paid based on the IRS requirements.
The IRS is examining the Company’s U.S. federal income tax returns for the fiscal years ended June 30, 2019, and June 28, 2020. As of December 25, 2022, no significant adjustments have been proposed by the IRS. The Company is unable to make a reasonable estimate as to when cash settlements, if any, with the IRS will occur.
The Company is in various stages of examinations in connection with all of its tax audits worldwide, and it is difficult to determine when these examinations will be settled. It is reasonably possible that over the next 12-month period the Company may experience an increase or decrease in its uncertain tax positions as a result of tax examinations or lapses of statutes of limitation. The change in uncertain tax positions as a result of lapses of statutes of limitation may range up to $18.4 million.
NOTE 7 — NET INCOME PER SHARE
Basic net income per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed using the treasury stock method, for dilutive stock options, restricted stock units, and convertible notes. The following table reconciles the inputs to the basic and diluted computations for net income per share.

| Three Months Ended |  | Six Months Ended
| December 25, 2022 |  | December 26, 2021 |  | December 25, 2022 |  | December 26, 2021
| (in thousands, except per share data)
Numerator: |  |  |  |  |  |  |
Net income | $ | 1,468,507 |  |  | $ | 1,194,830 |  |  | $ | 2,894,386 |  |  | $ | 2,374,574 |
Denominator: |  |  |  |  |  |  |
Basic average shares outstanding | 136,018 |  |  | 140,630 |  |  | 136,455 |  |  | 141,187 |
Effect of potential dilutive securities: |  |  |  |  |  |  |
Employee stock plans | 321 |  |  | 900 |  |  | 319 |  |  | 884 |
Diluted average shares outstanding | 136,339 |  |  | 141,530 |  |  | 136,774 |  |  | 142,071 |
Net income per share - basic | $ | 10.80 |  |  | $ | 8.50 |  |  | $ | 21.21 |  |  | $ | 16.82 |
Net income per share - diluted | $ | 10.77 |  |  | $ | 8.44 |  |  | $ | 21.16 |  |  | $ | 16.71 |

For purposes of computing diluted net income per share, weighted-average common shares do not include potentially dilutive securities that are anti-dilutive under the treasury stock method. The impact from potentially dilutive securities, including options and RSUs, was not material for the three and six months ended December 25, 2022 and December 26, 2021.
Lam Research Corporation 2023 Q2 10-Q 12

Table of Contents
NOTE 8 — FINANCIAL INSTRUMENTS
The Company maintains an investment portfolio of various holdings, types, and maturities. The Company’s mutual funds, which are related to the Company’s obligations under the deferred compensation plan, are classified as trading securities. Investments classified as trading securities are recorded at fair value based upon quoted market prices. Differences between the cost and fair value of trading securities are recognized as other income (expense), net in the Condensed Consolidated Statements of Operations. All of the Company’s debt securities are classified as available-for-sale and consequently are recorded in the Condensed Consolidated Balance Sheets at fair value with unrealized gains or losses associated with market valuation changes, unrelated to credit losses, reported as a separate component of accumulated other comprehensive income (loss), net of tax; and credit losses, if any, recognized as other income (expense), net in the Condensed Consolidated Statements of Operations.
The Company periodically invests in equity securities. For equity investments that do not have a readily determinable fair value, the Company records them using either 1) the measurement alternative which measures the equity investments at cost minus impairment, if any, plus or minus changes resulting from qualifying observable price changes; or 2) the equity method whereby the Company recognizes its proportional share of the income or loss from the equity method investment on a one-quarter lag. The equity method is utilized when the Company does not have the ability to control the investee but is deemed to have the ability to exercise significant influence over the investee’s operating or financial policies. For equity investments that have a readily determinable fair value, the Company records them at fair market value on a recurring basis based upon quoted market prices. Realized and unrealized gains and losses resulting from application of the measurement alternative, the impact of the application of the equity method to the Company’s equity investments, and recognition of changes in fair market value, as applicable, are recognized as other income (expense), net in the Condensed Consolidated Statements of Operations.
Fair Value
The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact, and it considers assumptions that market participants would use when pricing the asset or liability.
A fair value hierarchy has been established that prioritizes the inputs to valuation techniques used to measure fair value. The level of an asset or liability in the hierarchy is based on the lowest level of input that is significant to the fair value measurement. Assets and liabilities carried at fair value are classified and disclosed in one of the following three categories:
Level 1: Valuations based on quoted prices in active markets for identical assets or liabilities with sufficient volume and frequency of transactions.
Level 2: Valuations based on observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active for identical assets or liabilities, or model-derived valuations techniques for which all significant inputs are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3: Valuations based on unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities and based on non-binding, broker-provided price quotes and may not have been corroborated by observable market data.
The Company engages with pricing vendors to provide fair values for a majority of its Level 1 and Level 2 investments. The vendors provide either a quoted market price or use observable inputs without applying significant adjustments in their pricing. Significant observable inputs include interest rates and yield curves observable at commonly quoted intervals, volatility and credit risks. The fair value of derivative contracts is determined using observable market inputs such as the foreign currency rates, forward rate curves, currency volatility and interest rates and considers nonperformance risk of the Company and its counterparties.
The Company’s primary financial instruments include its cash, cash equivalents, investments, restricted cash and investments, long-term investments, accounts receivable, accounts payable, long-term debt and leases, and foreign currency related derivative instruments. The estimated fair value of cash, time deposits, accounts receivable, and accounts payable approximates their carrying value due to the short period of time to their maturities. The estimated fair values of lease obligations approximate their carrying value as the majority of these obligations have interest rates that adjust to market rates on a periodic basis. The fair value of the Company’s senior notes is based on the quoted price (level 2); the fair value of the Company's senior notes have not changed materially to that disclosed in Note 14, “Long Term Debt and Other Borrowings,” to the Company’s Consolidated Financial Statements in Part II, Item 8 of our 2022 Form 10-K.
Equity Investments measured at fair value on a non-recurring basis
As of December 25, 2022, and June 26, 2022, equity investments of $121.3 million and $125.2 million, respectively, were reported in other assets in the Condensed Consolidated Balance Sheets.
Lam Research Corporation 2023 Q2 10-Q 13

Table of Contents
With the exception of one equity investee that became publicly traded during the three and six months ended December 26, 2021, net gains resulting from the application of the measurement alternative to the Company’s equity investments were immaterial for the three and six months ended December 25, 2022, and December 26, 2021. Refer to Note 5 - Other Income (Expense), net for additional information regarding the gain associated with an equity investee that became publicly traded in the three and six months ended December 26, 2021.
Debt and Equity Investments measured at fair value on a recurring basis
The following tables set forth the Company’s cash, cash equivalents, investments, restricted cash and investments, and other assets measured at fair value on a recurring basis as of December 25, 2022, and June 26, 2022:

| December 25, 2022
|  |  |  |  |  |  |  |  | (Reported Within)
| Cost |  | Unrealized Gain |  | Unrealized (Loss) |  | Fair Value |  | Cash and Cash Equivalents |  | Investments |  | Restricted Cash & Investments |  | Other Assets
| (in thousands)
Level 1: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Money market funds | $ | 1,034,870 |  |  | $ | — |  |  | $ | — |  |  | $ | 1,034,870 |  |  | $ | 1,033,219 |  |  | $ | — |  |  | $ | — |  |  | $ | 1,651 |
Mutual funds | 81,889 |  |  | 12,051 |  |  | (2,801) |  |  | 91,139 |  |  | — |  |  | — |  |  | — |  |  | 91,139 |
Level 1 Total | 1,116,759 |  |  | 12,051 |  |  | (2,801) |  |  | 1,126,009 |  |  | 1,033,219 |  |  | — |  |  | — |  |  | 92,790 |
Level 2: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Corporate notes and bonds | 104,585 |  |  | 4 |  |  | (1,459) |  |  | 103,130 |  |  | — |  |  | 103,130 |  |  | — |  |  | — |
Level 2 Total | 104,585 |  |  | 4 |  |  | (1,459) |  |  | 103,130 |  |  | — |  |  | 103,130 |  |  | — |  |  | — |
Total subject to fair value hierarchy | $ | 1,221,344 |  |  | $ | 12,055 |  |  | $ | (4,260) |  |  | $ | 1,229,139 |  |  |  |  |  |  |  |  |
Cash |  |  |  |  |  |  | $ | 2,022,649 |  |  | $ | 2,021,333 |  |  | $ | — |  |  | $ | 1,316 |  |  | $ | — |
Time deposits |  |  |  |  |  |  | 1,680,192 |  |  | 1,430,164 |  |  | — |  |  | 250,028 |  |  | — |
Total |  |  |  |  |  |  | $ | 4,931,980 |  |  | $ | 4,484,716 |  |  | $ | 103,130 |  |  | $ | 251,344 |  |  | $ | 92,790 |

| June 26, 2022
|  |  |  |  |  |  |  |  | (Reported Within)
| Cost |  | Unrealized Gain |  | Unrealized (Loss) |  | Fair Value |  | Cash and Cash Equivalents |  | Investments |  | Restricted Cash & Investments |  | Other Assets
| (in thousands)
Level 1: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Money market funds | $ | 712,076 |  |  | $ | — |  |  | $ | — |  |  | $ | 712,076 |  |  | $ | 712,076 |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Mutual funds | 84,851 |  |  | 12,027 |  |  | (1,659) |  |  | 95,219 |  |  | — |  |  | — |  |  | — |  |  | 95,219 |
Level 1 Total | 796,927 |  |  | 12,027 |  |  | (1,659) |  |  | 807,295 |  |  | 712,076 |  |  | — |  |  | — |  |  | 95,219 |
Level 2: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Corporate notes and bonds | 137,859 |  |  | — |  |  | (2,128) |  |  | 135,731 |  |  | — |  |  | 135,731 |  |  | — |  |  | — |
Level 2 Total | 137,859 |  |  | — |  |  | (2,128) |  |  | 135,731 |  |  | — |  |  | 135,731 |  |  | — |  |  | — |
Total subject to fair value hierarchy | $ | 934,786 |  |  | $ | 12,027 |  |  | $ | (3,787) |  |  | $ | 943,026 |  |  |  |  |  |  |  |  |
Cash |  |  |  |  |  |  | $ | 1,017,253 |  |  | $ | 1,015,747 |  |  | $ | — |  |  | $ | 1,506 |  |  | $ | — |
Time deposits |  |  |  |  |  |  | 2,044,206 |  |  | 1,794,178 |  |  | — |  |  | 250,028 |  |  | — |
Total |  |  |  |  |  |  | $ | 4,004,485 |  |  | $ | 3,522,001 |  |  | $ | 135,731 |  |  | $ | 251,534 |  |  | $ | 95,219 |

The Company accounts for its investment portfolio at fair value. Realized gains (losses) for investment sales are specifically identified. Management assesses the fair value of investments in debt securities that are not actively traded through consideration of interest rates and their impact on the present value of the cash flows to be received from the investments.
The Company evaluates its investments with fair value less than amortized cost by first considering whether the Company has the intent to sell the security or whether it is more likely than not that the Company will be required to sell the security before recovery of its amortized cost basis. In either such situation, the difference between fair value and amortized cost is recognized as a loss in the income statement. Where such sales are not likely to occur, the Company considers whether a portion of the loss is the result of a credit loss. To the extent such losses are the result of credit losses, those amounts are recognized in the income statement. All other differences between fair value and amortized cost are recognized in other comprehensive income. No such losses were recognized through the income statement during the three and six months ended December 25, 2022 and December 26, 2021.
Lam Research Corporation 2023 Q2 10-Q 14

Table of Contents
Gross realized gains/(losses) from sales of investments were insignificant in the three and six months ended December 25, 2022 and December 26, 2021.
The following is an analysis of the Company’s investments in unrealized loss positions:

| December 25, 2022
| Unrealized Losses Less than 12 Months |  | Unrealized Losses 12 Months or Greater |  | Total
| Fair Value |  | Gross Unrealized Loss |  | Fair Value |  | Gross Unrealized Loss |  | Fair Value |  | Gross Unrealized Loss
| (in thousands)
Mutual funds | $ | 29,021 |  |  | $ | (2,526) |  |  | $ | 1,468 |  |  | $ | (275) |  |  | $ | 30,489 |  |  | $ | (2,801) |
Corporate notes and bonds | 80,426 |  |  | (1,215) |  |  | 18,526 |  |  | (244) |  |  | 98,952 |  |  | (1,459) |
| $ | 109,447 |  |  | $ | (3,741) |  |  | $ | 19,994 |  |  | $ | (519) |  |  | $ | 129,441 |  |  | $ | (4,260) |

The amortized cost and fair value of cash equivalents, investments, and restricted investments with contractual maturities are as follows as of December 25, 2022:

| Cost |  | Fair Value
| (in thousands)
Due in one year or less | $ | 2,790,470 |  |  | $ | 2,789,635 |
Due after one year through five years | 27,526 |  |  | 26,906 |
| $ | 2,817,996 |  |  | $ | 2,816,541 |

The Company has the ability, if necessary, to liquidate its investments in order to meet the Company’s liquidity needs in the next 12 months. Accordingly, those investments with contractual maturities greater than 12 months from the date of purchase nonetheless are classified as short-term on the accompanying Condensed Consolidated Balance Sheets.
Derivative Instruments and Hedging
The Company’s hedging strategies and policies are unchanged from those disclosed in Note 9, “Financial Instruments,” to our Consolidated Financial Statements in Part II, Item 8 of our 2022 Form 10-K. The financial statement impacts from derivative instruments and hedging activities were not material as of and for the three and six months ended December 25, 2022 and December 26, 2021.
Concentrations of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, investments, restricted cash and investments, trade accounts receivable, and derivative financial instruments used in hedging activities. Cash is placed on deposit at large, global financial institutions. Such deposits may be in excess of insured limits. Management believes that the financial institutions that hold the Company’s cash are creditworthy and, accordingly, minimal credit risk exists with respect to these balances.
The Company’s overall portfolio of available-for-sale securities must maintain an average minimum rating of “AA-” or “Aa3” as rated by Standard and Poor’s, Fitch Ratings, or Moody’s Investor Services. To ensure diversification and minimize concentration, the Company’s policy limits the amount of credit exposure with any one financial institution or commercial issuer.
The Company is exposed to credit losses in the event of nonperformance by counterparties on foreign currency and interest rate hedge contracts that are used to mitigate the effect of exchange rate and interest rate fluctuations, and on contracts related to structured share repurchase arrangements. These counterparties are large global financial institutions, and, to date, no such counterparty has failed to meet its financial obligations to the Company.
Credit risk evaluations, including trade references, bank references, and Dun & Bradstreet ratings, are performed on all new customers and the Company monitors its customers’ financial condition and payment performance. In general, the Company does not require collateral on sales.
Lam Research Corporation 2023 Q2 10-Q 15

Table of Contents
NOTE 9 — INVENTORIES
Inventories are stated at the lower of cost (first-in, first-out method) or net realizable value. System shipments to customers in Japan, for which title does not transfer until customer acceptance, are classified as finished goods inventory and carried at cost until title transfers. Inventories consist of the following:

| December 25, 2022 |  | June 26, 2022
| (in thousands)
Raw materials | $ | 3,156,162 |  |  | $ | 2,401,490 |
Work-in-process | 384,390 |  |  | 471,348 |
Finished goods | 1,279,414 |  |  | 1,093,456 |
| $ | 4,819,966 |  |  | $ | 3,966,294 |

NOTE 10 — GOODWILL AND INTANGIBLE ASSETS
Goodwill
The balance of goodwill is approximately $1.6 billion and $1.5 billion as of December 25, 2022 and June 26, 2022, respectively. As of December 25, 2022 and June 26, 2022, $62.0 million of the goodwill balance is tax deductible and the remaining balance is not tax deductible due to purchase accounting and applicable foreign law. Refer to Note 1 7 - Business Combination s for additional information regarding the Company’s goodwill balance.
Intangible Assets
The following table provides the Company’s intangible assets, other than goodwill:

| December 25, 2022 |  | June 26, 2022
| Gross |  | Accumulated Amortization |  | Net |  | Gross |  | Accumulated Amortization |  | Net
| (in thousands)
Customer relationships | $ | 644,102 |  |  | $ | (629,176) |  |  | $ | 14,926 |  |  | $ | 633,252 |  |  | $ | (627,376) |  |  | $ | 5,876 |
Existing technology | 717,247 |  |  | (668,279) |  |  | 48,968 |  |  | 676,924 |  |  | (664,278) |  |  | 12,646 |
Patents and other intangible assets | 191,676 |  |  | (100,870) |  |  | 90,806 |  |  | 167,821 |  |  | (84,493) |  |  | 83,328 |
Intangible assets subject to amortization | 1,553,025 |  |  | (1,398,325) |  |  | 154,700 |  |  | 1,477,997 |  |  | (1,376,147) |  |  | 101,850 |
In process research and development | 30,081 |  |  | — |  |  | 30,081 |  |  | — |  |  | — |  |  | — |
Total intangible assets | $ | 1,583,106 |  |  | $ | (1,398,325) |  |  | $ | 184,781 |  |  | $ | 1,477,997 |  |  | $ | (1,376,147) |  |  | $ | 101,850 |

The Company recognized $12.2 million and $19.5 million in intangible asset amortization expense during the three months ended December 25, 2022 and December 26, 2021, respectively. The Company recognized $23.8 million and $38.6 million in intangible asset amortization expense during the six months ended December 25, 2022 and December 26, 2021, respectively.
The estimated future amortization expense of intangible assets as of December 25, 2022, is reflected in the table below. The table excludes $27.7 million of capitalized costs for internal-use software that have not been placed into service.

Fiscal Year | Amount
| (in thousands)
2023 (remaining 6 months) | $ | 23,642 |
2024 | 35,098 |
2025 | 23,094 |
2026 | 14,289 |
2027 | 11,657 |
Thereafter | 19,237 |
| $ | 127,017 |

Refer to Note 1 7 - Business Combination s for additional information regarding the Company’s intangible assets.
Lam Research Corporation 2023 Q2 10-Q 16

Table of Contents
NOTE 11 — ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
Accrued expenses and other current liabilities consist of the following:

| December 25, 2022 |  | June 26, 2022
| (in thousands)
Accrued compensation | $ | 551,639 |  |  | $ | 481,070 |
Warranty reserves | 284,150 |  |  | 232,248 |
Income and other taxes payable | 310,656 |  |  | 465,601 |
Dividend payable | 233,977 |  |  | 205,615 |
Other | 687,948 |  |  | 589,738 |
| $ | 2,068,370 |  |  | $ | 1,974,272 |

NOTE 12 — LONG-TERM DEBT AND OTHER BORROWINGS
Revolving Credit Facility
On March 12, 2014, the Company established an unsecured Credit Agreement. This agreement was amended on November 10, 2015 (the “Amended and Restated Credit Agreement”), October 13, 2017 (the “2nd Amendment”), February 25, 2019 (the “3rd Amendment”), June 17, 2021 (the “Second Amended and Restated Credit Agreement”), and December 7, 2022 (“Amendment No.1 to Second Amended and Restated Credit Agreement”). The Amendment No.1 To Second Amended and Restated Credit Agreement replaces the benchmark reference rate, LIBOR, with term SOFR equal to the term rate determined by the CME term SOFR administrator plus 0.10% (“adjusted term SOFR”), with no change to the amount or timing of contractual cash flows.
Interest on amounts borrowed under the credit facility is, at the Company’s option, based on (1) a base rate, defined as the greatest of (a) prime rate, (b) Federal Funds rate plus 0.5%, or (c) adjusted term SOFR plus 1.0%, plus a spread of 0.00% to 0.30%, or (2) adjusted term SOFR, plus a spread of 0.805% to 1.30%, in each case plus a facility fee, with such spread and facility fee determined based on the rating of the Company’s non-credit enhanced, senior unsecured long-term debt. Such spreads and such facility fees are further subject to sustainability adjustments as described in the Amendment No.1 To Second Amended and Restated Credit Agreement, in each case based on the Company’s performance of certain energy savings and health and safety standards metrics. As of December 25, 2022, the Company had no borrowings outstanding under the credit facility and was in compliance with all financial covenants.
NOTE 13 — LEASES
The Company leases certain office spaces, manufacturing and warehouse spaces, equipment, and vehicles. While the majority of the Company’s lease arrangements are operating leases, the Company has certain leases that qualify as finance leases.
Selected Leases and Related Guarantees
The Company leases the majority of its administrative, research and development and manufacturing facilities, regional sales/service offices, and certain equipment under non-cancelable leases. Certain of the Company’s facility leases for buildings located at its Fremont, California headquarters, Tualatin, Oregon campus, and certain other facility leases provide the Company with options to extend the leases for additional periods or to purchase the facilities. Certain of the Company’s facility leases provide for periodic rent increases based on the general rate of inflation.
The Company has finance leases for certain improved properties in Fremont and Livermore, California (the “California Facility Leases”). The Company is required to maintain cash collateral in an aggregate of approximately $250.0 million in separate interest-bearing accounts as security for the Company’s obligations. These amounts are recorded with other restricted cash and investments in the Company’s Condensed Consolidated Balance Sheet as of December 25, 2022.
During the seven-year term of the California Facility Leases and when the terms of the California Facility Leases expire, the property subject to the California Facility Leases may be re-marketed. The Company has guaranteed to the lessor that each property will have a certain minimum residual value. The aggregate maximum guarantee made by the Company under the California Facility Leases is $298.4 million.
NOTE 14 — COMMITMENTS AND CONTINGENCIES
Refer to Note 13 - Leases for details regarding guarantees surrounding selected leases.
Lam Research Corporation 2023 Q2 10-Q 17

Table of Contents
Other Guarantees
The Company has issued certain indemnifications to its lessors for taxes and general liability under some of its agreements. The Company has entered into insurance contracts that are intended to limit its exposure to such indemnifications. As of December 25, 2022, the Company had not recorded any liability on its Condensed Consolidated Financial Statements in connection with these indemnifications, as it does not believe that it is probable that any material amounts will be paid under these guarantees.
Generally, the Company indemnifies, under pre-determined conditions and limitations, its customers for infringement of third-party intellectual property rights by the Company’s products or services. The Company seeks to limit its liability for such indemnity to an amount not to exceed the sales price of the products or services subject to its indemnification obligations. The Company does not believe that it is probable that any material amounts will be paid under these guarantees.
The Company provides guarantees and standby letters of credit to certain parties as required for certain transactions initiated during the ordinary course of business. As of December 25, 2022, the maximum potential amount of future payments that the Company could be required to make under these arrangements and letters of credit was $98.6 million. The Company does not believe, based on historical experience and information currently available, that it is probable that any material amounts will be required to be paid.
In addition, the Company has entered into indemnification agreements with its directors, officers, and certain other employees, consistent with its Bylaws and Certificate of Incorporation; and under local law, the Company may be required to provide indemnification to its employees for actions within the scope of their employment. Although the Company maintains insurance contracts that cover some of the potential liability associated with these indemnification agreements, there is no guarantee that all such liabilities will be covered. The Company does not believe, based on historical experience and information currently available, that it is probable that any material amounts will be required to be paid under such indemnification agreements or statutory obligations.
Warranties
The Company provides standard warranties on its systems. The liability amount is based on actual historical warranty spending activity by type of system, customer, and geographic region, modified for any known differences such as the impact of system reliability improvements. As of December 25, 2022, warranty reserves totaling $34.8 million were recognized in other long-term liabilities, the remainder were included in accrued expenses and other current liabilities in the Company’s Condensed Consolidated Balance Sheets.
Changes in the Company’s product warranty reserves were as follows:

| Three Months Ended |  | Six Months Ended
| December 25, 2022 |  | December 26, 2021 |  | December 25, 2022 |  | December 26, 2021
| (in thousands)
Balance at beginning of period | $ | 283,514 |  |  | $ | 214,244 |  |  | $ | 256,258 |  |  | $ | 191,758 |
Warranties issued during the period | 83,364 |  |  | 71,437 |  |  | 171,577 |  |  | 142,109 |
Settlements made during the period | (61,838) |  |  | (68,126) |  |  | (126,734) |  |  | (128,418) |
Changes in liability for warranties issued during the period | 3,210 |  |  | — |  |  | 1,941 |  |  | — |
Changes in liability for pre-existing warranties | 10,719 |  |  | 10,833 |  |  | 15,927 |  |  | 22,939 |
Balance at end of period | $ | 318,969 |  |  | $ | 228,388 |  |  | $ | 318,969 |  |  | $ | 228,388 |

Legal Proceedings
While the Company is not currently a party to any legal proceedings that it believes material, the Company is either a defendant or plaintiff in various actions that have arisen from time to time in the normal course of business, including intellectual property claims. The Company accrues for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Significant judgment is required in both the determination of probability and the determination as to whether a loss is reasonably estimable. Based on current information, the Company does not believe that a material loss from known matters is probable and therefore has not recorded an accrual of any material amount for litigation or other contingencies related to existing legal proceedings.
Lam Research Corporation 2023 Q2 10-Q 18

Table of Contents
NOTE 15 — STOCK REPURCHASE PROGRAM
In May 2022, the Board of Directors authorized the Company to repurchase up to an additional $5.0 billion of Common Stock; this authorization supplements the remaining balances from any prior authorizations. These repurchases can be conducted on the open market or as private purchases and may include the use of derivative contracts with large financial institutions, in all cases subject to compliance with applicable law. This repurchase program has no termination date and may be suspended or discontinued at any time.
Repurchases under the repurchase program were as follows during the periods indicated:

Period | Total Number of Shares Repurchased |  | Total Cost of Repurchase |  | Average Price Paid Per Share (1) |  | Amount Available Under Repurchase Program
| (in thousands, except per share data)
Available balance as of June 26, 2022 |  |  |  |  |  |  | $ | 5,514,636 |
Quarter ended September 25, 2022 | 675 |  | (2) |  | $ | 104,982 |  |  | $ | 432.74 |  |  | $ | 5,409,654 |
Quarter ended December 25, 2022 | 1,125 |  |  | $ | 483,226 |  |  | $ | 429.42 |  |  | $ | 4,926,428 |

(1) Average price paid per share excludes the effect of accelerated share repurchase activities. See additional disclosure below regarding the Company’s accelerated share repurchase activity during the six months ended December 25, 2022.
(2) Includes shares received at final settlement of accelerated share repurchase agreements; see additional disclosures below regarding the Company’s accelerated share repurchase activity during the six months ended December 25, 2022.
In addition to the shares repurchased under the Board-authorized repurchase program shown above, during the three and six months ended December 25, 2022, the Company acquired 8 thousand shares at a total cost of $3.1 million and 19 thousand shares at a total cost of $7.9 million, respectively, which the Company withheld through net settlements to cover minimum tax withholding obligations upon the vesting of restricted stock unit awards granted under the Company’s equity compensation plans. The shares retained by the Company through these net share settlements are not a part of the Board-authorized repurchase program but instead are authorized under the Company’s equity compensation plan.
Accelerated Share Repurchase Agreements
On June 2, 2022, the Company entered into an accelerated share repurchase agreement (the "June 2022 ASR") with two financial institutions to repurchase a total of $500 million of Common Stock. The Company took an initial delivery of approximately 717 thousand shares, which represented 75% of the prepayment amount divided by our closing stock price on June 2, 2022. The total number of shares received under the June 2022 ASR was based upon the average daily volume weighted average price of the Company’s Common Stock during the repurchase period, less an agreed upon discount. Final settlement of the June 2022 ASR occurred in September 2022, resulting in the receipt of approximately 433 thousand additional shares, which yielded a weighted-average share price of $435.20 for the transaction period.
NOTE 16 — ACCUMULATED OTHER COMPREHENSIVE LOSS
The components of accumulated other comprehensive loss, net of tax at December 25, 2022, as well as the activity for the six months ending December 25, 2022, were as follows:

| Accumulated Foreign Currency Translation Adjustment |  | Accumulated Unrealized Gain or Loss on Cash flow hedges |  | Accumulated Unrealized Holding Gain or Loss on Available-For-Sale Investments |  | Accumulated Unrealized Components of Defined Benefit Plans |  | Total
| (in thousands)
Balance at June 26, 2022 | $ | (81,755) |  |  | $ | (12,330) |  |  | $ | (1,637) |  |  | $ | (14,260) |  |  | $ | (109,982) |
Other comprehensive income before reclassifications | 7,861 |  |  | 185 |  |  | 570 |  |  | 572 |  |  | 9,188 |
Gains reclassified from accumulated other comprehensive loss to net income (1) | — |  |  | (8,024) |  |  | (53) |  |  | — |  |  | (8,077) |
Net current-period other comprehensive income (loss) | 7,861 |  |  | (7,839) |  |  | 517 |  |  | 572 |  |  | 1,111 |
Balance at December 25, 2022 | $ | (73,894) |  |  | $ | (20,169) |  |  | $ | (1,120) |  |  | $ | (13,688) |  |  | $ | (108,871) |

(1) Amount of after-tax gains reclassified from AOCI into net income is not material in the aggregate, or to any individual location in our Condensed Consolidated Statements of Operations.
Lam Research Corporation 2023 Q2 10-Q 19

Table of Contents
NOTE 17 — BUSINESS COMBINATIONS
In November 2022, the Company completed two business combination transactions acquiring the outstanding shares of two separate private companies in cash transactions valued at $153.8 million as of the respective purchase dates. The Company’s preliminary assessment of acquisition date fair value of the assets acquired and liabilities assumed resulted in the recognition of $100.4 million of goodwill and $81.2 million of intangible assets; all other assets acquired and all liabilities assumed were immaterial. The preliminary fair value of net tangible liabilities assumed and intangible assets acquired was based on preliminary valuations, estimates, and assumptions which are subject to change within the measurement period (up to one year from the acquisition date). The Company expensed all associated costs, as incurred, in selling, general, and administrative expense in the Condensed Consolidated Statement of Operations for the three and six months ended December 25, 2022.
The following table is a summary of the preliminary fair value estimates of the identifiable intangible assets and their useful lives:

| Weighted-Average Useful Life |  | Estimated Purchase Date Fair Value
|  |  | (in thousands)
Existing technology | 7 years |  | $ | 40,294 |
Customer relationships | 8 years |  | 10,835 |
In process research and development | Indefinite |  | 30,081 |
|  |  | $ | 81,210 |

NOTE 18 — SUBSEQUENT EVENT
In January 2023, the Company announced its plan to reduce headcount by approximately 1,300 employees as part of restructuring activity that will commence in the three months ended March 26, 2023. The Company estimates it will incur approximately $80.0 million in connection with this activity.
Lam Research Corporation 2023 Q2 10-Q 20

Table of Contents
ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
With the exception of historical facts, the statements contained in this discussion are forward-looking statements, which are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Certain, but not all, of the forward-looking statements in this report are specifically identified as forward-looking, by use of phrases and words such as “believe,” “estimated,” “anticipate,” “expect,” “probable,” “intend,” “plan,” “aim,” “may,” “should,” “could,” “would,” “will,” “continue,” and other future-oriented terms. The identification of certain statements as “forward-looking” does not mean that other statements not specifically identified are not forward-looking. Forward-looking statements include but are not limited to statements that relate to: trends and opportunities in the global economic environment; trends and opportunities in the semiconductor industry, including in the end markets and applications for semiconductors, and in device complexity; growth or decline in the industry and the market for, and spending on, wafer fabrication equipment; the anticipated levels of, and rates of change in, margins, market share, served addressable market, capital expenditures, research and development expenditures, international sales, revenue (actual and/or deferred), operating expenses and earnings generally; management’s plans and objectives for our current and future operations and business focus; volatility in our quarterly results; the makeup of our customer base; customer and end user requirements and our ability to satisfy those requirements; customer spending and demand for our products and services, and the reliability of indicators of change in customer spending and demand; the effect of variability in our customers’ business plans or demand for our products and services; our competition, and our ability to defend our market share and to gain new market share; the success of joint development and collaboration relationships with customers, suppliers, or others; outsourced activities; our supply chain and the role of suppliers in our business, including the impacts of supply chain constraints and material costs; our leadership and competency, and our ability to facilitate innovation; our research and development programs; our ability to create sustainable differentiation; technology inflections in the industry and our ability to identify those inflections and to invest in research and development programs to meet them; our ability to deliver multi-product solutions; the resources invested to comply with evolving standards and the impact of such efforts; changes in state, federal and international tax laws, our estimated annual tax rate and the factors that affect our tax rates; legal and regulatory compliance; the estimates we make, and the accruals we record, in order to implement our critical accounting policies (including but not limited to the adequacy of prior tax payments, future tax benefits or liabilities, and the adequacy of our accruals relating to them); hedging transactions; debt or financing arrangements; our investment portfolio; our access to capital markets; uses of, payments of, and impact of interest rate fluctuations on, our debt; our intention to pay quarterly dividends and the amounts thereof, if any; our ability and intention to repurchase our shares; credit risks; controls and procedures; recognition or amortization of expenses; our ability to manage and grow our cash position; our strategic relevance with our customers; our ability to scale our operations to respond to changes in our business; the value of our patents; the materiality of potential losses arising from legal proceedings; the probability of making payments under our guarantees; the impact of the COVID-19 pandemic; and the sufficiency of our financial resources or liquidity to support future business activities (including but not limited to operations, investments, debt service requirements, dividends, and capital expenditures). Such statements are based on current expectations and are subject to risks, uncertainties, and changes in condition, significance, value, and effect, including without limitation those discussed below under the heading “Risk Factors” within Part II Item 1A and elsewhere in this report and other documents we file from time to time with the Securities and Exchange Commission (“SEC”), such as our annual report on Form 10-K for the year ended June 26, 2022 (our “2022 Form 10-K”), our quarterly report on Form 10-Q for the fiscal quarter ended September 25, 2022, and our current reports on Form 8-K. Such risks, uncertainties, and changes in condition, significance, value, and effect could cause our actual results to differ materially from those expressed in this report and in ways not readily foreseeable. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof and are based on information currently and reasonably known to us. We do not undertake any obligation to release the results of any revisions to these forward-looking statements, which may be made to reflect events or circumstances that occur after the date of this report or to reflect the occurrence or effect of anticipated or unanticipated events.
Documents To Review In Connection With Management’s Discussion and Analysis Of Financial Condition and Results Of Operations
For a full understanding of our financial position and results of operations for the three and six months ended December 25, 2022, and the related Management’s Discussion and Analysis of Financial Condition and Results of Operations below, you should also read the Condensed Consolidated Financial Statements and notes presented in this Form 10-Q and the financial statements and notes in our 2022 Form 10-K.
Lam Research Corporation 2023 Q2 10-Q 21

Table of Contents
EXECUTIVE SUMMARY
Lam Research Corporation is a global supplier of innovative wafer fabrication equipment and services to the semiconductor industry. We have built a strong global presence with core competencies in areas like nanoscale applications enablement, chemistry, plasma and fluidics, advanced systems engineering and a broad range of operational disciplines. Our products and services are designed to help our customers build smaller and better performing devices that are used in a variety of electronic products, including mobile phones, personal computers, servers, wearables, automotive vehicles, and data storage devices.
Our customer base includes leading semiconductor memory, foundry, and integrated device manufacturers that make products such as non-volatile memory, dynamic random-access memory, and logic devices. Their continued success is part of our commitment to driving semiconductor breakthroughs that define the next generation. Our core technical competency is integrating hardware, process, materials, software, and process control, enabling results on the wafer.
Semiconductor manufacturing, our customers’ business, involves the complete fabrication of multiple dies or integrated circuits on a wafer. This involves the repetition of a set of core processes and can require hundreds of individual steps. Fabricating these devices requires highly sophisticated process technologies to integrate an increasing array of new materials with precise control at the atomic scale. Along with meeting technical requirements, wafer processing equipment must deliver high productivity and be cost-effective.
Demand from cloud computing, 5G, the Internet of Things, and other markets is driving the need for increasingly powerful and cost-efficient semiconductors. At the same time, there are growing technical challenges with traditional two-dimensional scaling. These trends are driving significant inflections in semiconductor manufacturing, such as the increasing importance of vertical scaling strategies like three-dimensional architecture as well as multiple patterning to enable shrinks.
We believe we are in a strong position with our leadership and expertise in deposition, etch, and clean to facilitate some of the most significant innovations in semiconductor device manufacturing. Our Customer Support Business Group provides products and services to maximize installed equipment performance, predictability, and operational efficiency. Several factors create opportunity for sustainable differentiation for us: (i) our focus on research and development, with several on-going programs relating to sustaining engineering, product and process development, and concept and feasibility; (ii) our ability to effectively leverage cycles of learning from our broad installed base; (iii) our collaborative focus with semi-ecosystem partners; (iv) our ability to identify and invest in the breadth of our product portfolio to meet technology inflections; and (v) our focus on delivering our multi-product solutions with a goal to enhance the value of Lam’s solutions to our customers.
Calendar year 2022 was a solid investment year in wafer fabrication equipment spending driven by robust secular demand for semiconductors and increasing complexity in manufacturing NAND, DRAM, and foundry logic devices. However, the demand environment, particularly in memory, has weakened, and as a result, we expect a reduction in wafer fabrication equipment spending in calendar year 2023. Additionally, the United States government imposed new controls which significantly impact trade with China for the shipment of wafer fabrication equipment and related parts and services. We expect these regulatory conditions, and the slowing economic environment, to negatively impact our financial results in calendar year 2023. As a result of the expected reduced business levels, we announced a plan for the March 2023 quarter to reduce headcount by 1,300 employees, and we expect to incur charges of approximately $80.0 million in connection with the plan. Over the course of calendar year 2023, we are projecting expenditures in the range of $150.0 million to $250.0 million associated with various business process improvements and initiatives, inclusive of the March 2023 quarter restructuring activity. Over the longer term, we believe that secular demand for semiconductors combined with technology inflections in our industry, including 3D device scaling, multiple patterning, process flow, and advanced packaging chip integration, will drive sustainable growth and lead to an increase in the served addressable market for our products and services in the deposition, etch, and clean businesses.
In the quarter-ended December 25, 2022, customer demand was strong and with improvement in supply chain constraints we were able to fulfill shipments of many critical parts required for revenue recognition. Although we have seen improvements in both our operations and those of our suppliers, we may continue to experience supply shortages as well as inflationary cost pressures in at least the near term. Risks and uncertainties related to the COVID-19 pandemic, supply chain challenges, and inflationary pressures may continue to negatively impact our revenue and gross margin.
Lam Research Corporation 2023 Q2 10-Q 22

Table of Contents
The following table summarizes certain key financial information for the periods indicated below:

| Three Months Ended
| December 25, 2022 |  | September 25, 2022 |  |
| (in thousands, except per share data and percentages)
Revenue | $ | 5,277,569 |  |  | $ | 5,074,121 |  |  |
Gross margin | $ | 2,376,349 |  |  | $ | 2,336,835 |  |  |
Gross margin as a percent of total revenue | 45.0 | % |  | 46.1 | % |  |
Total operating expenses | $ | 696,187 |  |  | $ | 638,995 |  |  |
Net income | $ | 1,468,507 |  |  | $ | 1,425,879 |  |  |
Diluted net income per share | $ | 10.77 |  |  | $ | 10.39 |  |  |

In the December 2022 quarter, revenue increased 4.0% compared to the September 2022 quarter, driven by an increase in systems revenue as a result of the improving supply chain environment. We were able to fulfill shipments of critical parts which drove down our deferred revenue balance to $1,984 million at the end of the December 2022 quarter compared to $2,755 million as of the end of the September 2022 quarter. We aim to balance the requirements of our customers with the availability of resources, as well as performance to our operational and financial objectives. As a result, from time to time, we exercise discretion and judgment as to the timing and prioritization of manufacturing and deliveries of products, which has impacted, including in the current fiscal year, and may in the future impact, the timing of revenue recognition with respect to such products.
The decrease in gross margin as a percentage of revenue in the December 2022 quarter compared to the September 2022 quarter was primarily a result of unfavorable customer and pr oduct mix. T he increase in operating expenses in the December 2022 quarter compared to the September 2022 quarter was primarily driven by an increase in deferred compensation plan-related costs, outside service spending and supplies expense.
Our cash and cash equivalents, investments, and restricted cash and investments balances increased to $4.8 billion at the end of the December 2022 quarter compared to $4.6 billion at the end of the September 2022 quarter. This increase was primarily the result of $1,140.2 million of cash generated from operating activities, partially offset by $456.3 million of share repurchases, including net share settlement of employee stock-based compensation, $236.0 million of dividends paid to stockholders; and $163.4 million of capital expenditures. Employee headcount as of December 25, 2022 was approximately 19,200.
RESULTS OF OPERATIONS
Revenue

| Three Months Ended |  | Six Months Ended
| December 25, 2022 |  | September 25, 2022 |  |  |  | December 25, 2022 |  | December 26, 2021
Revenue (in millions) | $ | 5,278 |  |  | $ | 5,074 |  |  |  |  | $ | 10,352 |  |  | $ | 8,531 |
China | 24 | % |  | 30 | % |  |  |  | 27 | % |  | 31 | %
Korea | 20 | % |  | 17 | % |  |  |  | 19 | % |  | 23 | %
Taiwan | 19 | % |  | 22 | % |  |  |  | 20 | % |  | 17 | %
Japan | 11 | % |  | 9 | % |  |  |  | 10 | % |  | 11 | %
Southeast Asia | 10 | % |  | 11 | % |  |  |  | 10 | % |  | 9 | %
United States | 10 | % |  | 6 | % |  |  |  | 8 | % |  | 6 | %
Europe | 6 | % |  | 5 | % |  |  |  | 6 | % |  | 3 | %

Revenue for the December 2022 quarte r increased 4.0% from the September 2022 quarter primarily due to improving supply chain conditions which allowed us to fulfill shipments of critical parts.
Lam Research Corporation 2023 Q2 10-Q 23

Table of Contents
The following table presents our revenue disaggregated between system and customer support-related revenue:

| Three Months Ended |  | Six Months Ended
| December 25, 2022 |  | September 25, 2022 |  |  |  | December 25, 2022 |  | December 26, 2021
| (In thousands)
System revenue | $ | 3,547,518 |  |  | $ | 3,181,987 |  |  |  |  | $ | 6,729,505 |  |  | $ | 5,665,056 |
Customer support-related revenue and other | 1,730,051 |  |  | 1,892,134 |  |  |  |  | 3,622,185 |  |  | 2,866,013 |
| $ | 5,277,569 |  |  | $ | 5,074,121 |  |  |  |  | $ | 10,351,690 |  |  | $ | 8,531,069 |

Please refer to Note 3, “Revenue,” to the Condensed Consolidated Financial Statements of this Form 10-Q for additional information regarding the composition of the two categories into which revenue has been disaggregated.
The following table presents the percentages of leading- and non-leading-edge equipment and upgrade revenue to each of the primary markets we serve:

| Three Months Ended |  | Six Months Ended
| December 25, 2022 |  | September 25, 2022 |  |  |  | December 25, 2022 |  | December 26, 2021
Memory | 50 | % |  | 52 | % |  |  |  | 50 | % |  | 61 | %
Foundry | 31 | % |  | 34 | % |  |  |  | 33 | % |  | 28 | %
Logic/integrated device manufacturing | 19 | % |  | 14 | % |  |  |  | 17 | % |  | 11 | %

The decrease in the memory market for the six months ended December 25, 2022 as compared to the same period in 2021, is primarily due to decreases in DRAM investments by our customers during this time period.
Gross Margin

| Three Months Ended |  | Six Months Ended
| December 25, 2022 |  | September 25, 2022 |  |  |  | December 25, 2022 |  | December 26, 2021
| (in thousands, except percentages)
Gross margin | $ | 2,376,349 |  |  | $ | 2,336,835 |  |  |  |  | $ | 4,713,184 |  |  | $ | 3,954,670 |
Percent of revenue | 45.0 | % |  | 46.1 | % |  |  |  | 45.5 | % |  | 46.4 | %

Gross margin as a percentage of revenue was lower in the December 2022 quarter compared to the September 2022 quarter primarily as a result of unfavorable customer and product mix.
The decrease in gross margin as a percentage of revenue in the six months ended December 25, 2022 compared to the same period in the prior year was primarily driven by higher levels of manufacturing-related spending as a result of increased inflationary pressures, partially offset by favorable customer and product mix.
Research and Development

| Three Months Ended |  | Six Months Ended
| December 25, 2022 |  | September 25, 2022 |  |  |  | December 25, 2022 |  | December 26, 2021
| (in thousands, except percentages)
Research & development (“R&D”) | $ | 462,385 |  |  | $ | 433,375 |  |  |  |  | $ | 895,760 |  |  | $ | 785,971 |
Percent of revenue | 8.8 | % |  | 8.5 | % |  |  |  | 8.7 | % |  | 9.2 | %

We co ntinued to make significant R&D investments in the December 2022 quarter focused on leading-edge deposition, etch, clean and other semiconductor manufacturing processes. The increase in R&D expense in the December 2022 quarter compared to the September 2022 quarter was primarily driven by an increase of $14 million in spending for supplies and $11 million in deferred compensation plan-related costs.
The increase in R&D expense in the six months ended December 25, 2022 compared to the same period in the prior year was primarily driven by increases in employee-related expenses mainly as a result of increased headcount as well as for $32 million in spending for supplies.
Lam Research Corporation 2023 Q2 10-Q 24

Table of Contents
Selling, General, and Administrative

| Three Months Ended |  | Six Months Ended
| December 25, 2022 |  | September 25, 2022 |  |  |  | December 25, 2022 |  | December 26, 2021
| (in thousands, except percentages)
Selling, general, and administrative (“SG&A”) | $ | 233,802 |  |  | $ | 205,620 |  |  |  |  | $ | 439,422 |  |  | $ | 458,327 |
Percent of revenue | 4.4 | % |  | 4.1 | % |  |  |  | 4.2 | % |  | 5.4 | %

SG&A expense during the December 2022 quart er increased in comparison to the September 2022 quarter, primarily driven by an increase of $14 million in outside service spending.
SG&A expense during the six months ended December 25, 2022 decreased compared to the same period in the prior year, primarily driven by a decrease of $23 million in amortization for intangible assets, as the intangible assets associated with our Novellus Systems, Inc. transactions have fully amortized.
Other Income (Expense), Net
Other income (expense), net consisted of the following:

| Three Months Ended |  | Six Months Ended
| December 25, 2022 |  | September 25, 2022 |  |  |  | December 25, 2022 |  | December 26, 2021
| (in thousands)
Interest income | $ | 26,125 |  |  | $ | 15,056 |  |  |  |  | $ | 41,181 |  |  | $ | 7,050 |
Interest expense | (46,661) |  |  | (46,052) |  |  |  |  | (92,713) |  |  | (91,821) |
Gains (losses) on deferred compensation plan-related assets, net | 10,871 |  |  | (12,726) |  |  |  |  | (1,855) |  |  | 7,381 |
Foreign exchange (losses) gains, net | (10,114) |  |  | 6,821 |  |  |  |  | (3,293) |  |  | 714 |
Other, net | (8,455) |  |  | (6,194) |  |  |  |  | (14,649) |  |  | 65,818 |
| $ | (28,234) |  |  | $ | (43,095) |  |  |  |  | $ | (71,329) |  |  | $ | (10,858) |

Interest income increased for the three months ended December 25, 2022 compared to the September 2022 quarter, and the six months ended December 25, 2022, compared to the same period in 2021, primarily because of higher yields partially offset by lower average balances.
Interest expense is consistent across all periods presented.
The gains and losses on deferred compensation plan-related assets were driven by fluctuations in the fair market value of the underlying funds for all periods presented.
Foreign exchange fluctuations were primarily due to currency movements against portions of our unhedged balance sheet exposures for all periods presented.
The losses in other, net for the three and six months ended December 25, 2022, were driven by fluctuations in fair value of equity investments. For the six months ended December 26, 2021, other, net includes an unrealized gain totaling $46.6 million associated with an equity investment that completed a business combination and public offering during that period.
Income Tax Expense
Our provision for income taxes and effective tax rate for the periods indicated were as follows:

| Three Months Ended |  | Six Months Ended
| December 25, 2022 |  | September 25, 2022 |  |  |  | December 25, 2022 |  | December 26, 2021
| (in thousands, except percentages)
Income tax expense | $ | 183,421 |  |  | $ | 228,866 |  |  |  |  | $ | 412,287 |  |  | $ | 324,940 |
Effective tax rate | 11.1 | % |  | 13.8 | % |  |  |  | 12.5 | % |  | 12.0 | %

Lam Research Corporation 2023 Q2 10-Q 25

Table of Contents
The decrease in the effective tax rate for the December 2022 quarter compared to the September 2022 quarter was primarily due to the change in level and proportion of income in higher and lower tax jurisdictions in this quarter, recognition of previously unrecognized tax benefits from lapses of statutes of limitation, and a net tax benefit associated with legal entity restructuring.
The increase in the effective tax rate for the six months ended December 25, 2022 compared to the same period in the prior year was primarily due to the change in level and proportion of income in higher and lower tax jurisdictions.
International revenues account for a significant portion of our total revenues, such that a material portion of our pre-tax income is earned and taxed outside the United States. International pre-tax income is taxable in the United States at a lower effective tax rate than the federal statutory tax rate. Please refer to Note 7, “Income Taxes,” to our Consolidated Financial Statements in Part II, Item 8 of our 2022 Form 10-K for additional information.
We re-evaluate uncertain tax positions on a quarterly basis. This evaluation is based on factors including, but not limited to, changes in facts or circumstances, changes in tax law, effectively settled issues under audit, and new audit activity. Any change in recognition or measurement would result in the recognition of a tax benefit or an additional charge to the tax provision.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
Refer to our “Critical Accounting Policies and Estimates” included in Part II, Item 7 of our 2022 Form 10-K for a discussion of our critical accounting policies and estimates.
Recent Accounting Pronouncements
For a description of recent accounting pronouncements, including the expected dates of adoption and estimated effects, if any, on our Condensed Consolidated Financial Statements, see Note 2 - Recent Accounting Pronouncements, of our Condensed Consolidated Financial Statements, included in Part 1 of this Form 10-Q.
LIQUIDITY AND CAPITAL RESOURCES
Total gross cash, cash equivalents, investments, and restricted cash and investments balances were $4.8 billion at December 25, 2022 compared to $3.9 billion as of June 26, 2022. This increase was primarily driven by $2,329.8 million of cash generated from operating activities, partially offset by $566.1 million of share repurchases, including net share settlement on employee stock-based compensation; $441.6 million in dividends paid; and $303.4 million of capital expenditures.
Net cash provided by operating activities of $2,329.8 million during the six months ended December 25, 2022, consisted of (in thousands):

Net income | $ | 2,894,386 |
Non-cash charges: |
Depreciation and amortization | 161,165 |
Equity-based compensation expense | 144,194 |
Deferred income taxes | (140,296) |
Changes in operating asset and liability accounts | (739,652) |
Other | 9,978 |
| $ | 2,329,775 |

Significant changes in operating asset and liability accounts, net of foreign exchange impact, included the following uses of cash: increases in inventory of $894.5 million, along with a decrease in trade accounts payable of $116.3 million, accrued expenses and other liabilities of $92.3 million, and deferred profit of $19.9 million. The uses of cash are offset by the following sources of cash: decreases in accounts receivable of $249.1 million, and prepaid expense and other assets of $134.2 million.
Cash Flow from Investing Activities
Net cash used for investing activities during the six months ended December 25, 2022, was $395.1 million, primarily consisting of $303.4 million in capital expenditures and $120.0 million of net cash disbursed for business acquisitions, partially offset by proceeds from maturities of available-for-sale securities of $32.4 million.
Cash Flow from Financing Activities
Net cash used for financing activities during the six months ended December 25, 2022, was $973.2 million, primarily consisting of $566.1 million in treasury stock repurchases, including net share settlement on employee stock-based compensation, and $441.6 million in dividends paid, partially offset by $52.7 million combined proceeds from issuance of common stock.
Lam Research Corporation 2023 Q2 10-Q 26

Table of Contents
Liquidity
Given that the semiconductor industry is highly competitive and has historically experienced rapid changes in demand, we believe that maintaining sufficient liquidity reserves is important to support sustaining levels of investment in R&D and capital infrastructure. Anticipated cash flows from operations based on our current business outlook, combined with our current levels of cash, cash equivalents, and short-term investments as of December 25, 2022, are expected to be sufficient to support our anticipated levels of operations, investments, debt service requirements, capital expenditures, capital redistributions, and dividends through at least the next twelve months. However, uncertainty in the global economy and the semiconductor industry, as well as disruptions in credit markets, have in the past, and could in the future, impact customer demand for our products, as well as our ability to manage normal commercial relationships with our customers, suppliers, and creditors.
In the longer term, liquidity will depend to a great extent on our future revenues and our ability to appropriately manage our costs based on demand for our products and services. While we have substantial cash balances, we may require additional funding and need or choose to raise the required funds through borrowings or public or private sales of debt or equity securities. We believe that, if necessary, we will be able to access the capital markets on terms and in amounts adequate to meet our objectives. However, domestic and global macroeconomic and political conditions, or the ongoing COVID-19 pandemic, could cause disruptions to the capital markets and otherwise make any financing more challenging, and there can be no assurance that we will be able to obtain such financing on commercially reasonable terms or at all.
ITEM 3. Quantitative and Qualitative Disclosures about Market Risk
For financial market risks related to changes in interest rates, marketable equity security prices, and foreign currency exchange rates, refer to Part II, Item 7A, “Quantitative and Qualitative Disclosures About Market Risk”, in our 2022 Form 10-K. Our exposure related to market risk has not changed materially since June 26, 2022.
ITEM 4. Controls and Procedures
Design of Disclosure Controls and Procedures and Internal Control over Financial Reporting
We maintain disclosure controls and procedures and internal control over financial reporting that are designed to comply with Rule 13a-15 of the Exchange Act. In designing and evaluating the controls and procedures associated with each, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and that the effectiveness of controls cannot be absolute because the cost to design and implement a control to identify errors or mitigate the risk of errors occurring should not outweigh the potential loss caused by the errors that would likely be detected by the control. Moreover, we believe that a control system cannot be guaranteed to be 100% effective all of the time. Accordingly, a control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met.
Disclosure Controls and Procedures
As required by Exchange Act Rule 13a-15(b), as of December 25, 2022, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rule 13a-15(e). Based upon that evaluation, our Chief Executive Officer, along with our Chief Financial Officer, concluded that our disclosure controls and procedures are effective at the reasonable assurance level.
We intend to review and evaluate the design and effectiveness of our disclosure controls and procedures on an ongoing basis and to correct any material deficiencies that we may discover. Our goal is to ensure that our senior management has timely access to material information that could affect our business.
Changes in Internal Control over Financial Reporting
There has been no change in our internal control over financial reporting during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Effectiveness of Controls
While we believe the present design of our disclosure controls and procedures and internal control over financial reporting is effective, future events affecting our business may cause us to modify our disclosure controls and procedures or internal control over financial reporting.
Lam Research Corporation 2023 Q2 10-Q 27

Table of Contents
PART II. OTHER INFORMATION
ITEM 1. Legal Proceedings
Please refer to the subsection entitled “Legal Proceedings” within Note 14 “Commitments and Contingencies," to our Condensed Consolidated Financial Statements in this quarterly report on Form 10-Q.
ITEM 1A. Risk Factors
In addition to the other information in this Form 10-Q, the following risk factors should be carefully considered in evaluating us and our business because such factors may significantly impact our business, operating results, and financial condition. Many of the following risk factors have been, and could be further, exacerbated by the COVID-19 pandemic and any worsening of the global business and economic environment as a result. As a result of these risk factors, as well as other risks discussed in our other SEC filings, our actual results could differ materially from those projected in any forward-looking statements. No priority or significance is intended by, nor should be attached to, the order in which the risk factors appear.
INDUSTRY AND CUSTOMER RISKS
The Semiconductor Capital Equipment Industry Is Subject to Variability and Periods of Rapid Growth or Decline; We Therefore Face Risks Related to Our Strategic Resource Allocation Decisions
The semiconductor capital equipment industry has historically been characterized by rapid changes in demand. The industry environment has moved toward being more characterized by variability across segments and customers, accentuated by consolidation within the industry. Variability in our customers’ business plans may lead to changes in demand for our equipment and services, which could negatively impact our results. The variability in our customers’ investments during any particular period is dependent on several factors, including but not limited to electronics demand, economic conditions (both general and in the semiconductor and electronics industries), industry supply and demand, prices for semiconductors, and our customers’ ability to develop and manufacture increasingly complex and costly semiconductor devices. The changes in demand may require our management to adjust spending and other resources allocated to operating activities.
During periods of rapid growth or decline in demand for our products and services, we face significant challenges in maintaining adequate financial and business controls, management processes, information systems, and procedures for training, assimilating, and managing our workforce, and in appropriately sizing our supply chain infrastructure and facilities, work force, and other components of our business on a timely basis. If we do not adequately meet these challenges during periods of increasing or declining demand, our gross margins and earnings may be negatively impacted. For example, the COVID-19 pandemic has impacted and could in the future impact our ability to meet the demand for our products due to production, sourcing, logistics and other challenges resulting from quarantines, shelter in place or “stay at home” orders, facility closures, workforce challenges, and travel and logistics restrictions in connection with the pandemic.
We continuously reassess our strategic resource allocation choices in response to the changing business environment. If we do not adequately adapt to the changing business environment, we may lack the infrastructure and resources to scale up our business to meet customer expectations and compete successfully during a period of growth, or we may expand our capacity and resources too rapidly and/or beyond what is appropriate for the actual demand environment, resulting in excess fixed costs.
Especially during transitional periods, resource allocation decisions can have a significant impact on our future performance, particularly if we have not accurately anticipated industry changes. Our success will depend, to a significant extent, on the ability of our executive officers and other members of our senior management to identify and respond to these challenges effectively.
Future Declines in the Semiconductor Industry, and the Overall World Economic Conditions on Which It Is Significantly Dependent, Could Have a Material Adverse Impact on Our Results of Operations and Financial Condition
Our business depends on the capital equipment expenditures of semiconductor manufacturers, which in turn depend on the current and anticipated market demand for integrated circuits. With the consolidation of customers within the industry, the semiconductor capital equipment market may experience rapid changes in demand driven both by changes in the market generally and the plans and requirements of particular customers. The economic, political, and business conditions occurring nationally, globally, or in any of our key sales regions, which are often unpredictable, have historically impacted customer demand for our products and normal commercial relationships with our customers, suppliers, and creditors. Additionally, in times of economic uncertainty, our customers’ budgets for our products, or their ability to access credit to purchase them, could be adversely affected. This would limit their ability to purchase our products and services. As a result, changing economic, political or business conditions can cause material adverse changes to our results of operations and financial condition, including but not limited to:
•a decline in demand for our products or services;
Lam Research Corporation 2023 Q2 10-Q 28

Table of Contents
•an increase in reserves on accounts receivable due to our customers’ inability to pay us;
•an increase in reserves on inventory balances due to excess or obsolete inventory as a result of our inability to sell such inventory;
•valuation allowances on deferred tax assets;
•restructuring charges;
•asset impairments including the potential impairment of goodwill and other intangible assets;
•a decline in the value of our investments;
•exposure to claims from our suppliers for payment on inventory that is ordered in anticipation of customer purchases that do not come to fruition;
•a decline in the value of certain facilities we lease to less than our residual value guarantee with the lessor; and
•challenges maintaining reliable and uninterrupted sources of supply.
Fluctuating levels of investment by semiconductor manufacturers may materially affect our aggregate shipments, revenues, operating results, and earnings. Where appropriate, we will attempt to respond to these fluctuations with cost management programs aimed at aligning our expenditures with anticipated revenue streams, which sometimes result in restructuring charges. Even during periods of reduced revenues, we must continue to invest in R&D and maintain extensive ongoing worldwide customer service and support capabilities to remain competitive, which may temporarily harm our profitability and other financial results.
We Have a Limited Number of Key Customers
Sales to a limited number of large customers constitute a significant portion of our overall revenue, shipments, cash flows, collections, and profitability. As a result, the actions of even one customer may subject us to variability in those areas that is difficult to predict. In addition, large customers may be able to negotiate requirements that result in decreased pricing, increased costs, and/or lower margins for us; compliance with specific environmental, social, and corporate governance standards; and limitations on our ability to share technology with others. Similarly, significant portions of our credit risk may, at any given time, be concentrated among a limited number of customers so that the failure of even one of these key customers to pay its obligations to us could significantly impact our financial results.
We Face a Challenging and Complex Competitive Environment
We face significant competition from multiple competitors, and with increased consolidation efforts in our industry, as well as the emergence and strengthening of new, regional competitors, we may face increasing competitive pressures. Other companies continue to develop systems and/or acquire businesses and products that are competitive to ours and may introduce new products and product capabilities that may affect our ability to sell and support our existing products. We face a greater risk if our competitors enter into strategic relationships with leading semiconductor manufacturers covering products similar to those we sell or may develop, as this could adversely affect our ability to sell products to those manufacturers.
We believe that to remain competitive we must devote significant financial resources to offer products that meet our customers’ needs, to maintain customer service and support centers worldwide, and to invest in product and process R&D. Technological changes and developing technologies, have required, and are expected to continue to require, new and costly investments. Certain of our competitors, including those that are created and financially backed by foreign governments, have substantially greater financial resources and more extensive engineering, manufacturing, marketing, and customer service and support resources than we do and therefore have the potential to offer customers a more comprehensive array of products and/or product capabilities and to therefore achieve additional relative success in the semiconductor equipment industry. These competitors may deeply discount or give away products similar to those that we sell, challenging or even exceeding our ability to make similar accommodations and threatening our ability to sell those products. We also face competition from our own customers, who in some instances have established affiliated entities that manufacture equipment similar to ours. In addition, we face competition from companies that exist in a more favorable legal or regulatory environment than we do, allowing the freedom of action in ways that we may be unable to match. In many cases speed to solution is necessary for customer satisfaction and our competitors may be better positioned to achieve these objectives. For these reasons, we may fail to continue to compete successfully worldwide.
In addition, our competitors may be able to develop products comparable or superior to those we offer or may adapt more quickly to new technologies or evolving customer requirements. In particular, while we continue to develop product enhancements that we believe will address future customer requirements, we may fail in a timely manner to complete the development or introduction of these additional product enhancements successfully, or these product enhancements may not achieve market acceptance or be competitive. Accordingly, competition may intensify, and we may be unable to continue to compete successfully in our markets, which could have a material adverse effect on our revenues, operating results, financial condition, and/or cash flows.
Lam Research Corporation 2023 Q2 10-Q 29

Table of Contents
Once a Semiconductor Manufacturer Commits to Purchase a Competitor’s Semiconductor Manufacturing Equipment, the Manufacturer Typically Continues to Purchase That Competitor’s Equipment, Making It More Difficult for Us to Sell Our Equipment to That Customer
Semiconductor manufacturers must make a substantial investment to qualify and integrate wafer processing equipment into a semiconductor production line. We believe that once a semiconductor manufacturer selects a particular supplier’s processing equipment, the manufacturer generally relies upon that equipment for that specific production line application for an extended period of time, especially for customers that are more focused on tool reuse. Accordingly, we expect it to be more difficult to sell our products to a given customer for a product line application if that customer initially selects a competitor’s equipment for the same product line application.
We Depend on Creating New Products and Processes and Enhancing Existing Products and Processes for Our Success; Consequently, We Are Subject to Risks Associated with Rapid Technological Change
Rapid technological changes in semiconductor manufacturing processes subject us to increased pressure to develop technological advances that enable those processes. We believe that our future success depends in part upon our ability to develop and offer new products with improved capabilities and to continue to enhance our existing products. If new products or existing products have reliability, quality, design, or safety problems, our performance may be impacted by reduced orders, higher manufacturing costs, delays in acceptance of and payment for new products, and additional service and warranty expenses. We may be unable to develop and manufacture products successfully, or products that we introduce may fail in the marketplace. For more than 25 years, the primary driver of technology advancement in the semiconductor industry has been to shrink the lithography that prints the circuit design on semiconductor chips. That driver could be approaching its technological limit, leading semiconductor manufacturers to investigate more complex changes in multiple technologies in an effort to continue technology development. In addition, the emergence of “big data” and new tools such as machine learning and artificial intelligence that capitalize on the availability of large data sets is leading semiconductor manufacturers and equipment manufacturers to pursue new products and approaches that exploit those tools to advance technology development. In the face of uncertainty on which technology solutions will become successful, we will need to focus our efforts on developing the technology changes that are ultimately successful in supporting our customer requirements. Our failure to develop and offer the correct technology solutions in a timely manner with productive and cost-effective products could adversely affect our business in a material way. Our failure to commercialize new products in a timely manner could result in loss of market share, unanticipated costs, and inventory obsolescence, which would adversely affect our financial results.
In order to develop new products and processes and enhance existing products and processes, we expect to continue to make significant investments in R&D, to investigate the acquisition of new products and technologies, to invest in or acquire such business or technologies, and to pursue joint development relationships with customers, suppliers, or other members of the industry. Our investments and acquisitions may not be as successful as we may expect, particularly in the event that we invest in or acquire product lines and technologies that are new to us. We may find that acquisitions are not available to us, for regulatory or other reasons, and that we must therefore limit ourselves to collaboration and joint venture development activities, which do not have the same benefits as acquisitions. Pursuing development through collaboration and/or joint development activities rather than through an acquisition poses substantial challenges for management, including those related to aligning business objectives; sharing confidential information, intellectual property and data; sharing value with third parties; and realizing synergies that might have been available in an acquisition but are not available through a joint development project. We must manage product transitions and joint development relationships successfully, as the introduction of new products could adversely affect our sales of existing products and certain jointly developed technologies may be subject to restrictions on our ability to share that technology with other customers, which could limit our market for products incorporating those technologies. Future technologies, processes, or product developments may render our current product offerings obsolete, leaving us with non-competitive products, obsolete inventory, or both. Moreover, customers may adopt new technologies or processes to address the complex challenges associated with next-generation devices. This shift may result in a reduction in the size of our addressable markets or could increase the relative size of markets in which we either do not compete or have relatively low market share.
Strategic Alliances and Customer Consolidation May Have Negative Effects on Our Business
Increasingly, semiconductor manufacturing companies are entering into strategic alliances or consolidating with one another to expedite the development of processes and other manufacturing technologies and/or achieve economies of scale. The outcomes of such an alliance can be the definition of a particular tool set for a certain function and/or the standardization of a series of process steps that use a specific set of manufacturing equipment, while the outcomes of consolidation can lead to an overall reduction in the market for semiconductor manufacturing equipment as customers’ operations achieve economies of scale and/or increased purchasing power based on their higher volumes. In certain instances, this could work to our disadvantage if a competitor’s tools or equipment become the standard equipment for such functions or processes. Additional outcomes of such consolidation may include our customers re-evaluating their future supplier relationships to consider our competitors’ products and/or gaining additional influence over the pricing of products and the control of intellectual property or data.
Similarly, our customers may partner with, or follow the lead of, educational or research institutions that establish processes for accomplishing various tasks or manufacturing steps. If those institutions utilize a competitor’s equipment when they establish those processes, it is likely that customers will tend to use the same equipment in setting up their own manufacturing lines. Even
Lam Research Corporation 2023 Q2 10-Q 30

Table of Contents
if they select our equipment, the institutions and the customers that follow their lead could impose conditions on acceptance of that equipment, such as adherence to standards and requirements or limitations on how we license our proprietary rights, that increase our costs or require us to take on greater risk. These actions could adversely impact our market share and financial results.
BUSINESS AND OPERATIONAL RISKS
Our Revenues and Operating Results Are Variable
Our revenues and operating results may fluctuate significantly from quarter to quarter or year to year due to a number of factors, not all of which are in our control. We manage our expense levels based in part on our expectations of future revenues. Because our operating expenses are based in part on anticipated future revenues, and a certain amount of those expenses are relatively fixed, a change in the timing of recognition of revenue and/or the level of gross profit from a small number of transactions can unfavorably affect operating results in a particular quarter or year. Factors that may cause our financial results to fluctuate unpredictably include but are not limited to:
•legal, tax, accounting, or regulatory changes (including but not limited to changes in import/export regulations and tariffs, such as regulations imposed by the U.S. government restricting exports to China) or changes in the interpretation or enforcement of existing requirements;
•macroeconomic conditions, increased risk of recession, and geopolitical issues;
•changes in average selling prices, customer mix, and product mix;
•foreign currency exchange rate fluctuations;
•economic conditions in the electronics and semiconductor industries in general and specifically the semiconductor equipment industry;
•the size and timing of orders from customers;
•changes in our deferred revenue balance, including as a result of factors such as volume purchase agreements, multi-year service contracts, back orders, and down payments toward purchases;
•consolidation of the customer base, which may result in the investment decisions of one customer or market having a significant effect on demand for our products or services;
•procurement shortages;
•the failure of our suppliers or outsource providers to perform their obligations in a manner consistent with our expectations;
•manufacturing difficulties;
•customer cancellations or delays in shipments, installations, customer payments, and/or customer acceptances;
•the extent that customers continue to purchase and use our products and services in their business;
•our customers’ reuse of existing and installed products, to the extent that such reuse decreases their need to purchase new products or services;
•our ability to develop, introduce, and market new, enhanced, and competitive products in a timely manner;
•our competitors’ introduction of new products;
•legal or technical challenges to our products and technologies;
•transportation, communication, demand, information technology, or supply disruptions based on factors outside our control, such as strikes, acts of God, wars, terrorist activities, widespread outbreak of illness, natural or man-made disasters, or climate change;
•rising inflation or interest rates; and
•changes in our estimated effective tax rate.
For example, the COVID-19 pandemic has impacted and could in the future impact our ability to meet the demand for our products due to production, sourcing, logistics and other challenges resulting from quarantines, shelter in place or stay at home orders, facility closures, workforce challenges, and travel and logistics restrictions in connection with the pandemic.
Our Future Success Depends Heavily on International Sales and the Management of Global Operations
Non-U.S. sales, as reflected in Part I Item 2. Results of Operations of this quarterly report on Form 10-Q, accounted for approximately 92%, 92%, and 94% of total revenue in the six months ended December 25, 2022 and fiscal years 2022, and 2021, respectively. We expect that international sales will continue to account for a substantial majority of our total revenue in future years.
We are subject to various challenges related to international sales and the management of global operations including, but not limited to:
•domestic and international trade regulations, policies, practices, relations, disputes and issues;
•domestic and international tariffs, export controls and other barriers;
•developing customers and/or suppliers, who may have limited access to capital resources;
•global or national economic and political conditions;
•changes in currency controls;
•differences in the enforcement of intellectual property and contract rights in varying jurisdictions;
Lam Research Corporation 2023 Q2 10-Q 31

Table of Contents
•our ability to respond to customer and foreign government demands for locally sourced systems, spare parts, and services and develop the necessary relationships with local suppliers;
•changes in and compliance with U.S. and international laws and regulations affecting foreign operations, including U.S. and international trade restrictions and sanctions, anti-bribery, anti-corruption, anti-boycott, environmental, tax, and labor laws;
•fluctuations in interest and foreign currency exchange rates;
•the need for technical support resources in different locations; and
•our ability to secure and retain qualified people, and effectively manage people, in all necessary locations for the successful operation of our business.
For example, the COVID-19 pandemic has impacted and could in the future impact our manufacturing operations, supply chain, and customer support due to production, sourcing, logistics and other challenges resulting from quarantines, stay at home orders, facility closures, workforce challenges, and travel and logistics restrictions in connection with the pandemic.
There is inherent risk, based on the complex relationships among China, Japan, Korea, Taiwan, and the United States, that political, diplomatic and national security influences can lead to trade disputes, impacts and/or disruptions, in particular those affecting the semiconductor industry. This can adversely affect our business with China, Japan, Korea, and/or Taiwan and perhaps the entire Asia Pacific region or global economy. A significant trade dispute, impact and/or disruption in any area where we do business could have a materially adverse impact on our future revenue and profits.
Tariffs, export controls, additional taxes, trade barriers, sanctions, the termination or modification of trade agreements, trade zones, and other duty mitigation initiatives, and any reciprocal retaliatory actions, can increase our manufacturing costs, decrease margins, reduce the competitiveness of our products, disrupt our supply chain operations, or inhibit our ability to sell products or provide services, which has had and in the future could have a material adverse effect on our business, results of operations, or financial conditions. Certain of our international sales depend on our ability to obtain export licenses from the U.S. or foreign governments, and our inability to obtain such licenses, or an expansion of the number or kinds of sales for which export licenses are required, has limited and could in the future further limit the market for our products and has had and could in the future have an adverse impact on our revenues. As is discussed below under the heading “Our Sales to Customers in China, a Significant Region for Us, Have Been Impacted, and are Likely to Be Materially and Adversely Affected by Export License Requirements and Other Regulatory Changes, or Other Governmental Actions in the Course of the Trade Relationship Between the U.S. and China,” the U.S. government has recently imposed new controls, including expanded export license requirements, that significantly impact trade with China. In addition, the U.S. government has an ongoing process of assessing technologies that may be subject to new or additional export controls, and it is possible that such additional controls, if and when imposed, could further adversely impact our ability to sell our products outside the U.S. The implementation by the U.S. government of broad export controls restricting access to our technology (such as recent controls limiting exports to China) may cause customers with international operations to reconsider their use of and reliance on our products, which could adversely impact our future revenue and profits. Furthermore, there are risks that foreign governments may, among other things, take retaliatory actions; insist on the use of local suppliers; compel companies to partner with local companies to design and supply equipment on a local basis, requiring the transfer of intellectual property rights and/or local manufacturing; utilize their influence over their judicial systems to respond to intellectual property disputes or issues; and provide special incentives to government-backed local customers to buy from local competitors, even if their products are inferior to ours; all of which could adversely impact our revenues and margins.
We are exposed to potentially adverse movements in foreign currency exchange rates. The majority of our sales and expenses are denominated in U.S. dollars. However, we are exposed to foreign currency exchange rate fluctuations primarily related to revenues denominated in Japanese yen and expenses denominated in euro, Korean won, Malaysian ringgit, and Indian rupee. Further, in periods in which the U.S. dollar is strong relative to the local currencies of our international customers can potentially reduce demand for our products, which may compound the adverse effect of foreign exchange translation on our revenue. Currently, we hedge certain anticipated foreign currency cash flows, primarily anticipated revenues denominated in Japanese yen and expenses dominated in euro, Korean won, Malaysian ringgit, and Indian rupee. In addition, we enter into foreign currency hedge contracts to minimize the short-term impact of the foreign currency exchange rate fluctuations on certain foreign currency denominated monetary assets and liabilities, primarily third-party accounts receivables, accounts payables, and intercompany receivables and payables. We believe these are our primary exposures to currency rate fluctuation. We expect to continue to enter into hedging transactions, for the purposes outlined, for the foreseeable future. However, these hedging transactions may not achieve their desired effect because differences between the actual timing of the underlying exposures and our forecasts of those exposures may leave us either over or under hedged on any given transaction. Moreover, by hedging these foreign currency denominated revenues, expenses, monetary assets, and liabilities, we may miss favorable currency trends that would have been advantageous to us but for the hedges. Additionally, we are exposed to short-term foreign currency exchange rate fluctuations on non-U.S. dollar-denominated monetary assets and liabilities (other than those currency exposures previously discussed), and currently we do not enter into foreign currency hedge contracts against these exposures. In addition, our currency hedges do not necessarily mitigate the potential negative impact of a strong U.S. dollar on demand for our products. Therefore, we are subject to potential unfavorable foreign currency exchange rate fluctuations to the extent that we transact business (including intercompany transactions) in these currencies.
Lam Research Corporation 2023 Q2 10-Q 32

Table of Contents
The magnitude of our overseas business also affects where our cash is generated. Certain uses of cash, such as share repurchases, payment of dividends, or the repayment of our notes, can usually only be made with onshore cash balances. Since the majority of our cash is generated outside of the United States, this may impact certain business decisions and outcomes.
Our Business Relies on Technology, Data, Intellectual Property and Other Sensitive Information That is Susceptible to Cybersecurity and Other Threats or Incidents
Our business is dependent upon the use and protection of technology, data, intellectual property and other sensitive information, which may be owned by, or licensed to, us or third parties, such as our customers and vendors. We maintain and rely upon certain critical information systems for the creation, transmission, use and storage of much of this information, and for the effective operation of our business. These information systems include but are not limited to, telecommunications, the Internet, our corporate intranet, various computer hardware and software applications, (some of which may be integrated into the products that we sell or be required in order to provide the services that we offer), network communications, and email. These information systems may be owned and maintained by us, our outsourced providers, or third parties such as vendors, contractors, customers and Cloud providers. In addition, we make use of Software-as-a-Service (SaaS) products for certain important business functions that are provided by third parties and hosted on their own networks and servers, or third-party networks and servers, all of which rely on networks, email and/or the Internet for their function.
The technology, data, intellectual property and other sensitive information we seek to protect are subject to loss, release, misappropriation or misuse, and the information systems containing or transmitting such technology, data, intellectual property and other sensitive information are subject to disruption, breach or failure, in each case as a result of various possible causes. Such causes may include mistakes or unauthorized actions by our employees or contractors, phishing schemes and other third-party attacks, and degradation or loss of service or access to data due to viruses, malware, denial of service attacks, destructive or inadequate code, power failures, or physical damage to computers, hard drives, communication lines, or networking equipment. Such causes may also include the use of techniques that change frequently or may be disguised or difficult to detect, or designed to remain dormant until a triggering event, or that may continue undetected for an extended period of time.
We have experienced cybersecurity and other threats and incidents in the past. Although past threats and incidents have not resulted in a material adverse effect, we may incur material losses related to cybersecurity and other threats or incidents in the future. If we were subject to a cybersecurity or other incident, it could have a material adverse effect on our business. Such adverse effects might include:
•loss of (or inability to access, e.g. through ransomware) confidential and/or sensitive information stored on these critical information systems or transmitted to or from those systems;
•the disruption of the proper function of our products, services and/or operations;
•the failure of our or our customers’ manufacturing processes;
•errors in the output of our work or our customers’ work;
•the loss or public exposure of the personal or other confidential information of our employees, customers or other parties;
•the public release of customer financial and business plans, customer orders and operational results;
•exposure to claims from our employees or third parties who are adversely impacted by such incidents;
•misappropriation or theft of our or a customer’s, supplier’s or other party’s assets or resources, including technology data, intellectual property or other sensitive information and costs associated therewith;
•reputational damage;
•diminution in the value of our investment in research, development and engineering; or
•our failure to meet, or violation of, regulatory or other legal obligations, such as the timely publication or filing of financial statements, tax information and other required communications.
While we have implemented ISO 27001 compliant security procedures and virus protection software, intrusion prevention systems, identity and access control, and emergency recovery processes, and we carefully select our third-party providers of information systems, to mitigate risks to the information systems that we rely on and to the technology, data, intellectual property and other sensitive information we seek to protect, those security procedures and mitigation and protection systems cannot be guaranteed to be fail-safe, and we may still suffer cybersecurity and other incidents. It has been difficult and may continue to be difficult to hire and retain employees with substantial cybersecurity acumen. In addition, there have been and may continue to be instances of our policies and procedures not being effective in enabling us to identify risks, threats and incidents in a timely manner, or at all, or to respond expediently, appropriately and effectively when incidents occur and repair any damage caused by such incidents, and such occurrences could have a material adverse effect on our business.
We May Not Achieve the Expected Benefits of Our Restructuring Plans and Business Transformation Initiatives, and These Efforts Could Have a Material Adverse Effect on Our Business, Operations, Financial Condition, Results of Operations and Competitive Position
In January 2023 we announced that we are implementing a restructuring plan consisting of a workforce reduction, and that we anticipate undertaking, and may in the future undertake, additional business restructuring, realignment and transformation initiatives. We expect to incur material costs and charges in connection with these plans and initiatives. While the restructuring plan is intended to better align our cost structure with the current economic environment and future business opportunities, and
Lam Research Corporation 2023 Q2 10-Q 33

Table of Contents
our anticipated transformation initiatives have the goal of strengthening our operations and achieving operational efficiencies, there can be no assurance that we will be successful in these plans and initiatives. Implementation of these plans and initiatives may be costly and disruptive to our business, we may not be able to complete them at the cost or within the time frame contemplated, and we may not be able to obtain the anticipated benefits within the projected timing or at all. Restructuring and transformation may adversely affect our internal programs and our ability to recruit and retain skilled and motivated personnel, may result in a loss of continuity, loss of accumulated knowledge and/or inefficiency during transitional periods, may require a significant amount of management and other employees' time and focus, and may be distracting to employees and management, which may divert attention from operating and growing our business. If we fail to achieve some or all of the expected benefits, it could have a material adverse effect on our business, operations, financial condition, results of operations and competitive position. For more information about our restructuring plan, see Note 18 to our Condensed Consolidated Financial Statements in Part I.
Disruptions to Our Supply Chain and Outsource Providers Could Impact Our Ability to Meet Demand, Increase Our Costs, and Adversely Impact Our Revenue and Operating Results
Our supply chain has played and will continue to play a key role in our product development, manufacturing operations, field installation and support. Our business depends on our timely supply of products and services to meet the demand from our customers, which depends in significant part on the timely delivery of parts, materials and services, including components and subassemblies, from our direct suppliers to us, and to our direct suppliers by other companies. In addition, outsource providers have played and will continue to play a key role both in the manufacturing and customer-focused operations described above, and in many of our transactional and administrative functions, such as information technology, facilities management, and certain elements of our finance organization. These providers and suppliers might suffer financial setbacks, be acquired by third parties, become subject to exclusivity arrangements that preclude further business with us, or be unable to meet our requirements or expectation due to their independent business decisions or force majeure events that could interrupt or impair their continued ability to perform as we expect. We may also experience significant interruptions of our manufacturing operations, delays in our ability to deliver or install products or perform services or to recognize revenue, increased costs or customer order cancellations as a result of:
•the failure or inability to accurately forecast demand and obtain sufficient quantities of quality parts on a cost-effective basis;
•volatility in the availability and cost of parts, materials or services, including increased costs due to rising inflation or interest rates or other market conditions;
•difficulties or delays in obtaining required import or export approvals;
•shipment delays and increased costs of shipment due to transportation interruptions, capacity constraints, or fuel shortages;
•shortages of semiconductor or other components or materials as a result of increases in demand;
•information technology or infrastructure failures, including those of a third-party supplier or service provider; and
•transportation or supply disruptions based on factors outside our control, such as strikes, acts of God, wars, terrorist activities, widespread outbreak of illness, natural or man-made disasters, or climate change.
Demand for electronic products and other factors, such as the COVID-19 pandemic and the conflict in Ukraine, have resulted in, and may continue to result in, a shortage of parts, materials and services needed to manufacture, deliver and install our products, as well as delays in and unpredictability of shipments due to transportation interruptions. Such shortages, delays and unpredictability have adversely impacted, and may continue to adversely impact, our suppliers’ ability to meet our demand requirements. Difficulties in obtaining sufficient and timely supply of parts, materials or services, and delays in and unpredictability of shipments due to transportation interruptions, have adversely impacted, and may continue to adversely impact, our manufacturing operations and our ability to meet customer demand. In addition, difficulties in obtaining parts, materials or services necessary to deliver or install products or perform services have adversely impacted, and may continue to adversely impact, our ability to recognize revenue, our gross margins on the revenue we recognize, and our other operating results. Although we are endeavoring to pass along some of the impact of increased costs to our customers to counteract adverse impacts to our gross margins and other operating results, such measures could be unsuccessful, or could have the effect of reducing demand, which would adversely impact our revenue.
Although we attempt to select reputable providers and suppliers and we attempt to secure their performance on terms documented in written contracts, it is possible that one or more of these providers or suppliers could fail to perform as we expect, or fail to secure or protect intellectual property rights, and such failure could have an adverse impact on our business. In some cases, the requirements of our business mandate that we obtain certain components and sub-assemblies included in our products from a single supplier or a limited group of suppliers. Where practical, we endeavor to establish alternative sources to mitigate the risk that the failure of any single provider or supplier will adversely affect our business, but this is not feasible in all circumstances. Some key parts are subject to long lead-times or available only from a single supplier or limited group of suppliers, and some sourcing or subassembly is provided by suppliers located in countries other than the countries where we conduct our manufacturing. There is therefore a risk that a prolonged inability to obtain certain components or secure key services could impair our ability to manage operations, ship products, and generate revenues, which could adversely affect our operating results and damage our customer relationships. For example, the COVID–19 pandemic has impacted and could in the future impact our manufacturing operations, supply chain, and customer support due to production, sourcing, logistics and other
Lam Research Corporation 2023 Q2 10-Q 34

Table of Contents
challenges resulting from quarantines, stay at home orders, facility closures, workforce challenges, and travel and logistics restrictions in connection with the pandemic.
The COVID-19 Pandemic Has Adversely Impacted, and May in the Future Adversely Impact, Our Business, Operations, and Financial Results
The COVID-19 pandemic and efforts by national, state and local governments worldwide to control its spread have resulted in measures aimed at containing the disease such as quarantines, travel bans, shutdowns, and shelter in place or “stay at home” orders, which collectively have significantly restricted the movement of people and goods and the ability of businesses to operate. These restrictions and measures, incidents of confirmed or suspected infections within our workforce or those of our suppliers or other business partners, and our efforts to act in the best interests of our employees, customers, and suppliers, have affected and in the future may affect our business and operations by, among other things, causing facility closures, production delays and capacity limitations; disrupting production by our supply chain; disrupting the transport of goods from our supply chain to us and from us to our customers; requiring modifications to our business processes; requiring the implementation of business continuity plans; requiring the development and qualification of alternative sources of supply; requiring the implementation of social distancing measures that impede manufacturing processes; disrupting business travel; disrupting our ability to staff our on-site manufacturing and research and development facilities; delaying capital expansion projects; and necessitating teleworking by portions of our workforce. These impacts have caused and in the future may cause delays in product shipments and product development, increases in costs, and decreases in revenue, profitability and cash from operations, which have caused and in the future may cause an adverse effect on our results of operations that may be material. The potential duration and impact of the pandemic on the global economy and on our business are difficult to predict and cannot be estimated with any degree of certainty, but the pandemic has resulted at various times in significant disruption of global financial markets, increases in levels of unemployment, and economic uncertainty, which has adversely impacted our business and may do so in the future, and may lead to significant negative impacts on customer spending, demand for our products, the ability of our customers to pay, our financial condition and the financial condition of our suppliers, and our access to external sources of financing to fund our operations and capital expenditures.
We Face Risks Related to the Disruption of Our Primary Manufacturing and R&D Facilities
While we maintain business continuity plans, our manufacturing and R&D facilities are concentrated in a limited number of locations. These locations are subject to disruption for a variety of reasons, such as natural or man-made disasters, widespread outbreaks of illness, terrorist activities, political or governmental unrest or instability, disruptions of our information technology resources, utility interruptions, the effects of climate change, or other events beyond our control. Such disruptions may cause delays in developing or shipping our products, in engaging with customers on new product applications, or in supporting customers, which could result in the loss of business or customer trust, adversely affecting our business and operating results. For example, the COVID-19 pandemic has impacted and could in the future impact our manufacturing operations, supply chain, R&D and customer support due to production, sourcing, logistics and other challenges resulting from quarantines, “stay at home” orders, facility closures, workforce challenges, and travel and logistics restrictions in connection with the pandemic.
We Are Subject to Risks Relating to Product Concentration and Lack of Product Revenue Diversification
We derive a substantial percentage of our revenues from a limited number of products. Our products are priced up to the tens of millions of dollars per system. As a result, the inability to recognize revenue on even a few systems can cause a significantly adverse impact on our revenues for a given quarter, and, in the longer term, the continued market acceptance of these products is critical to our future success. Our business, operating results, financial condition, and cash flows could therefore be adversely affected by:
•a decline in demand for even a limited number of our products;
•a failure to achieve continued market acceptance of our key products;
•export restrictions or other regulatory or legislative actions that could limit our ability to sell those products to key customers or customers within certain markets;
•an improved version of products being offered by a competitor in the markets in which we participate;
•increased pressure from competitors that offer broader product lines;
•increased pressure from regional competitors;
•technological changes that we are unable to address with our products; or
•a failure to release new or enhanced versions of our products on a timely basis.
In addition, the fact that we offer limited product lines creates the risk that our customers may view us as less important to their business than our competitors that offer additional products and/or product capabilities, including new products that take advantage of “big data” or other new technologies such as machine learning and artificial intelligence. This may impact our ability to maintain or expand our business with certain customers. Such product concentration may also subject us to additional risks associated with technology changes. Our business is affected by our customers’ use of our products in certain steps in their wafer fabrication processes. Should technologies change so that the manufacture of semiconductors requires fewer steps using our products, this could have a larger impact on our business than it would on the business of our less concentrated competitors.
Lam Research Corporation 2023 Q2 10-Q 35

Table of Contents
We May Fail to Protect Our Critical Proprietary Technology Rights, Which Could Affect Our Business
Our success depends in part on our proprietary technology and our ability to protect key components of that technology through patents, copyrights, trade secrets and other forms of protection. Protecting our key proprietary technology helps us achieve our goals of developing technological expertise and new products and systems that give us a competitive advantage; increasing market penetration and growth of our installed base; and providing comprehensive support and service to our customers. As part of our strategy to protect our technology, we currently hold a number of U.S. and foreign patents and pending patent applications, and we keep certain information, processes, and techniques confidential and/or as trade secrets. However, other parties may challenge or attempt to invalidate or circumvent any patents the U.S. or foreign governments issue to us; these governments may fail to issue patents for pending applications; or we may lose trade secret protection over valuable information due to our or third parties’ intentional or unintentional actions or omissions or even those of our own employees. Additionally, intellectual property litigation can be expensive and time-consuming and even when patents are issued, or trade secret processes are followed, the legal systems in certain of the countries in which we do business might not enforce patents and other intellectual property rights as rigorously or effectively as the United States or may favor local entities in their intellectual property enforcement. The rights granted or anticipated under any of our patents, pending patent applications, or trade secrets may be narrower than we expect or, in fact, provide no competitive advantages. Moreover, because we selectively file for patent protection in different jurisdictions, we may not have adequate protection in all jurisdictions based on such filing decisions. Any of these circumstances could have a material adverse impact on our business.
Our Ability to Attract, Retain, and Motivate Key Employees Is Critical to Our Success
Our ability to compete successfully depends in large part on our ability to attract, retain, and motivate key employees with the appropriate skills, experiences and competencies. This is an ongoing challenge due to intense competition for top talent, fluctuations in industry or business economic conditions, as well as increasing geographic expansion, and these factors in combination may result in cycles of hiring activity and workforce reductions. Our success in hiring depends on a variety of factors, including the attractiveness of our compensation and benefit programs, global economic or political and industry conditions, our organizational structure, global competition for talent and the availability of qualified employees, the availability of career development opportunities, the ability to obtain necessary authorizations for workers to provide services outside their home countries, and our ability to offer a challenging and rewarding work environment. We periodically evaluate our overall compensation and benefit programs and make adjustments, as appropriate, to maintain or enhance their competitiveness. If we are not able to successfully attract, retain, and motivate key employees, we may be unable to capitalize on market opportunities and our operating results may be materially and adversely affected.
If We Choose to Acquire or Dispose of Businesses, Product Lines, and Technologies, We May Encounter Unforeseen Costs and Difficulties That Could Impair Our Financial Performance
An important element of our management strategy is to review acquisition prospects that would complement our existing products, augment our market coverage and distribution ability, enhance our technological capabilities, or accomplish other strategic objectives. As a result, we may seek to make acquisitions of complementary companies, products, or technologies, or we may reduce or dispose of certain product lines or technologies that no longer fit our long-term strategies. For regulatory or other reasons, we may not be successful in our attempts to acquire or dispose of businesses, products, or technologies, resulting in significant financial costs, reduced or lost opportunities, and diversion of management’s attention. Managing an acquired business, disposing of product technologies, or reducing personnel entails numerous operational and financial risks, including difficulties in assimilating acquired operations and new personnel or separating existing business or product groups, diversion of management’s attention away from other business concerns, amortization of acquired intangible assets, adverse customer reaction to our decision to cease support for a product, and potential loss of key employees or customers of acquired or disposed operations. There can be no assurance that we will be able to achieve and manage successfully any such integration of potential acquisitions, disposition of product lines or technologies, or reduction in personnel, or that our management, personnel, or systems will be adequate to support continued operations. Any such inabilities or inadequacies could have a material adverse effect on our business, operating results, financial condition, and/or cash flows.
In addition, any acquisition could result in changes such as potentially dilutive issuances of equity securities, the incurrence of debt and contingent liabilities, the amortization of related intangible assets, and goodwill impairment charges, any of which could materially adversely affect our business, financial condition, results of operations, cash flows, and/or the price of our Common Stock.
LEGAL, REGULATORY AND TAX RISKS
Our Sales to Customers in China, a Significant Region for Us, Have Been Impacted, and are Likely to Be Materially and Adversely Affected by Export License Requirements and Other Regulatory Changes, or Other Governmental Actions in the Course of the Trade Relationship Between the U.S. and China
China represents a large and fast-developing market for the semiconductor equipment industry and therefore is important to our business. Revenue in China, which includes global customers and domestic Chinese customers with manufacturing facilities in China, represented approximately 27%, 31%, and 35% of our total revenue for the six months ended December 25, 2022 and fiscal years 2022 and 2021, respectively. The U.S. and China have historically had a complex relationship that has included
Lam Research Corporation 2023 Q2 10-Q 36

Table of Contents
actions that have impacted trade between the two countries. Recently, these actions have included an expansion of export license requirements imposed by the U.S. government, which have limited the market for our products, adversely impacted our revenues, and increased our exposure to foreign competition, and could potentially do so to an even greater extent in the future. Most recently, the U.S. government has enacted new rules aimed at restricting China’s ability to manufacture advanced semiconductors, which include restrictions on exports, reexports or transfers to, or shipping, transmitting, transferring, or facilitating such movement to, or performing services at, customer facilities in China engaged in certain technology end-uses, without appropriate authorizations obtained from U.S. authorities. In addition, the U.S. Department of Commerce has enacted new rules that have expanded export license requirements for U.S. companies to sell certain items to companies and other end-users in China that are designated as military end-users or have operations that could support military end uses; has added additional Chinese companies to its restricted entity list and unverified list under suspicion of military-civil fusion, support of Russia, or other factors associated with a broadening scope of national security concerns (including Semiconductor Manufacturing International Corporation, or SMIC, and related entities, and Yangtze Memory Technologies Co., Ltd., or YMTC, and related entities); and has expanded an existing rule (referred to as the foreign direct product rule) in a manner that could cause foreign-made wafers, chipsets, and certain related items produced with many of our products to be subject to U.S. licensing requirements if Huawei Technologies Co. Ltd (“Huawei”) or its affiliates are parties to a transaction involving the items. These rules have required and may require us to apply for and obtain additional export licenses to supply certain of our products to customers in China, such as SMIC, YMTC and ChangXin Memory Technologies, Inc., and there is no assurance that we will be issued licenses that we apply for on a timely basis or at all. In addition, our customers (including but not limited to Chinese customers) may require U.S. export licenses for the use of our products in order to manufacture products, including semiconductor wafers and integrated circuits, for those of their customers (i.e. Huawei and its affiliates) that are subject to the expanded foreign direct product rule, which may adversely impact the demand for our products. The U.S. Department of Commerce could in the future add additional Chinese companies to its restricted entity list or unverified list or take other actions that could expand licensing requirements or otherwise impact the market for our products and our revenue. The implementation, interpretation and impact on our business of these rules and other regulatory actions taken by the U.S. government is uncertain and evolving, and these rules, other regulatory actions or changes, and other actions taken by the governments of either the U.S. or China, or both, that have occurred and may occur in the future could materially and adversely affect our results of operations.
We Are Exposed to Various Risks from Our Regulatory Environment
We are subject to various risks related to (1) new, different, inconsistent, or even conflicting laws, rules, and regulations that may be enacted by legislative or executive bodies and/or regulatory agencies in the countries that we operate; (2) disagreements or disputes related to international trade; and (3) the interpretation and application of laws, rules, and regulations. As a public company with global operations, we are subject to the laws of multiple jurisdictions and the rules and regulations of various governing bodies, including those related to export controls, financial and other disclosures, corporate governance, privacy, anti-corruption, such as the Foreign Corrupt Practices Act and other local laws prohibiting corrupt payments to governmental officials, anti-boycott compliance, conflict minerals or other social responsibility legislation, immigration or travel regulations, antitrust regulations, and laws or regulations relating to carbon emissions, as well as other laws or regulations imposed in response to climate change concerns, among others. Each of these laws, rules, and regulations imposes costs on our business, including financial costs and potential diversion of our management’s attention associated with compliance, and may present risks to our business, including potential fines, restrictions on our actions, and reputational damage if we do not fully comply.
To maintain high standards of corporate governance and public disclosure, we intend to invest appropriate resources to comply with evolving standards. Changes in or ambiguous interpretations of laws, regulations, and standards may create uncertainty regarding compliance matters. Efforts to comply with new and changing regulations have resulted in, and are likely to continue to result in, reduced operating income, and a diversion of management’s time and attention from revenue-generating activities to compliance activities. If we are found by a court or regulatory agency not to be in compliance with the laws and regulations, our business, financial condition, and/or results of operations could be adversely affected.
Intellectual Property, Indemnity, and Other Claims Against Us Can Be Costly and We Could Lose Significant Rights That Are Necessary to Our Continued Business and Profitability
Third parties may assert infringement, misappropriation, unfair competition, product liability, breach of contract, or other claims against us. From time to time, other persons send us notices alleging that our products infringe or misappropriate their patent or other intellectual property rights. In addition, law enforcement authorities may seek criminal charges relating to intellectual property or other issues. We also face risks of claims arising from commercial and other relationships. In addition, our bylaws and other indemnity obligations provide that we will indemnify officers and members of our Board of Directors against losses that they may incur in legal proceedings resulting from their service to us. From time to time, in the normal course of business, we indemnify third parties with whom we enter into contractual relationships, including customers and suppliers, with respect to certain matters. We have agreed, under certain conditions, to hold these third parties harmless against specified losses, such as those arising from a breach of representations or covenants, other third-party claims that our products when used for their intended purposes infringe the intellectual property rights of such other third parties, or other claims made against certain parties. In such cases, it is our policy either to defend the claims or to negotiate licenses or other settlements on commercially reasonable terms. However, we may be unable in the future to negotiate necessary licenses or reach agreement on other settlements on commercially reasonable terms, or at all, and any litigation resulting from these claims by other parties may materially and adversely affect our business and financial results, and we may be subject to substantial damage awards and
Lam Research Corporation 2023 Q2 10-Q 37

Table of Contents
penalties. Moreover, although we have insurance to protect us from certain claims and cover certain losses to our property, such insurance may not cover us for the full amount of any losses, or at all, and may be subject to substantial exclusions and deductibles.
Our Financial Results May Be Adversely Impacted by Higher than Expected Tax Rates or Exposure to Additional Tax Liabilities
We are subject to income, transaction, and other taxes in the United States and various foreign jurisdictions, and significant judgment is required to determine worldwide tax liabilities. The amount of taxes we pay is subject to ongoing audits in various jurisdictions, and a material assessment by a governing tax authority could affect our profitability. As a global company, our effective tax rate is highly dependent upon the geographic composition of worldwide earnings and tax regulations governing each region. Our effective tax rate could be adversely affected by changes in the split of earnings between countries with differing statutory tax rates, in the valuation allowance of deferred tax assets, in tax laws, by material audit assessments, or by changes in or expirations of agreements with tax authorities. These factors could affect our profitability. In particular, the carrying value of deferred tax assets, which are predominantly in the United States, is dependent on our ability to generate future taxable income in the United States.
On August 16, 2022, the Inflation Reduction Act (the “IRA”) was signed into law. In general, the provisions of the IRA will be effective beginning with our fiscal year 2024, with certain exceptions. The IRA includes a new 15% corporate minimum tax as well as a 1% excise tax on corporate stock repurchases applicable to repurchases after December 31, 2022. We have evaluated the potential impacts of the IRA and do not expect it to have a material impact on our effective tax rate. However we expect future guidance from the Treasury Department and will further analyze when the guidance is issued.
Recommendations made by the Organization for Economic Co-operation and Development’s Base Erosion and Profit Shifting project have the potential to lead to changes in the tax laws in numerous countries. In addition, President Joseph Biden has made several corporate income tax proposals, including changes in the taxation of non-U.S. income. If enacted, such changes could have a material impact on our effective tax rate.
A Failure to Comply with Environmental Regulations May Adversely Affect Our Operating Results
We are subject to a variety of domestic and international governmental regulations related to the handling, discharge, and disposal of toxic, volatile, or otherwise hazardous chemicals. Failure to comply with present or future environmental regulations could result in fines being imposed on us, require us to undertake remediation activities, suspend production, and/or cease operations, or cause our customers to not accept our products. These regulations could require us to alter our current operations, acquire significant additional equipment, incur substantial other expenses to comply with environmental regulations, or take other actions. Any failure to comply with regulations governing the use, handling, sale, transport, or disposal of hazardous substances could subject us to future liabilities that may adversely affect our operating results, financial condition, and ability to operate our business.
Our Bylaws Designate the Court of Chancery of the State of Delaware as the Sole and Exclusive Judicial Forum for Certain Legal Actions Between the Company and its Stockholders, Which May Discourage Lawsuits with Respect to Such Claims
Our bylaws provide that, unless we consent otherwise, the Court of Chancery of the State of Delaware will be the sole and exclusive forum for lawsuits asserting certain stockholder claims (including claims asserted derivatively for our benefit), such as claims against directors and officers for breach of a fiduciary duty, claims arising under any provision of the General Corporation Law of Delaware or our certificate of incorporation or our bylaws, or claims governed by the internal affairs doctrine. This is a general summary of the bylaw provision; you should refer to the language of the bylaws for details. While the forum provision does not generally apply to direct claims arising under the Securities Exchange Act of 1934 or the Securities Act of 1933, derivative lawsuits that assert legal claims arising under these statutes could fall within the provision, as recent court decisions have held.
As a Delaware corporation, Delaware law controls issues of our internal affairs, including duties that our directors, officers, employees, and others owe to the Company and its stockholders. We believe that our exclusive forum provision benefits us, and our stockholders, by permitting relatively prompt resolution of lawsuits concerning our internal affairs, promoting consistent application of Delaware law in these lawsuits, and reducing the possibility of duplicative, costly, multi-jurisdictional litigation with the potential for inconsistent outcomes. However, the forum provision limits a stockholder’s ability to bring a claim in a judicial forum that it believes may be more favorable than Delaware, and this could discourage the filing of such lawsuits.
Lam Research Corporation 2023 Q2 10-Q 38

Table of Contents
FINANCIAL, ACCOUNTING AND CAPITAL MARKETS RISKS
The Market for Our Common Stock Is Volatile, Which May Affect Our Ability to Raise Capital or Make Acquisitions or May Subject Our Business to Additional Costs
The market price for our Common Stock is volatile and has fluctuated significantly over the past years. The trading price of our Common Stock could continue to be highly volatile and fluctuate widely in response to a variety of factors, many of which are not within our control or influence. These factors include but are not limited to the following:
•general market, semiconductor, or semiconductor equipment industry conditions;
•economic or political events, trends, and unexpected developments occurring nationally, globally, or in any of our key sales regions;
•changes in macroeconomic conditions, increased risk of recession, and geopolitical issues;
•variations in our quarterly operating results and financial condition, including our liquidity;
•variations in our revenues, earnings, or other business and financial metrics from forecasts by us or securities analysts or from those experienced by other companies in our industry;
•announcements of restructurings, reductions in force, departure of key employees, and/or consolidations of operations;
•margin trading, short sales, hedging and derivative transactions involving our Common Stock;
•government regulations;
•developments in, or claims relating to, patent or other proprietary rights;
•technological innovations and the introduction of new products by us or our competitors;
•commercial success or failure of our new and existing products; or
•disruptions of relationships with key customers or suppliers.
In addition, the stock market experiences significant price and volume fluctuations. Historically, we have witnessed significant volatility in the price of our Common Stock due in part to the price of and markets for semiconductors. These and other factors have adversely affected and may again adversely affect the price of our Common Stock, regardless of our actual operating performance. In the past, following volatile periods in the price of their stock, many companies became the object of securities class action litigation. If we are sued in a securities class action, we could incur substantial costs, and it could divert management’s attention and resources and have an unfavorable impact on our financial performance and the price for our Common Stock.
We May Incur Impairments to Goodwill or Long-lived Assets
We review our goodwill identified in business combinations for impairment annually or whenever events or changes in circumstances indicate that the carrying amount of these assets may exceed the fair value. We review all other long-lived assets, including finite-lived intangible assets, whenever events or changes in circumstance indicate that these assets may not be recoverable. The process of evaluating the potential impairment of goodwill and other long-lived assets requires significant judgement. Negative industry or economic trends, including reduced market prices of our Common Stock, reduced estimates of future cash flows, disruptions to our business, slower growth rates, or lack of growth in our relevant business units, could lead to impairment charges against our long-lived assets, including goodwill and other intangible assets.
When evaluating goodwill, if we conclude that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, then a quantitative impairment test is performed and we may be required to record an impairment charge in that period, which could adversely affect our result of operations.
When evaluating other long-lived assets, if we conclude that the estimated undiscounted cash flows attributable to the assets are less than their carrying value, we recognize an impairment loss based on the excess of the carrying amount of the assets over their respective fair values, which could adversely affect our results of operations.
Our valuation methodology for assessing impairment requires management to make judgments and assumptions based on historical experience and to rely heavily on projections of future operating performance. We operate in a highly competitive environment and projections of future operating results and cash flows may vary significantly from actual results. Additionally, if our analysis indicates potential impairment, we may be required to record additional charges to earnings in our financial statements, which could negatively affect our results of operations.
Our Leverage and Debt Service Obligations May Adversely Affect Our Financial Condition, Results of Operations, and Earnings per Share
We have $5.0 billion in aggregate principal amount of senior unsecured notes outstanding. Additionally, we have funding available to us under our $1.5 billion commercial paper program and our $1.5 billion revolving credit facility, which serves as a backstop to our commercial paper program. Our revolving credit facility also includes an option to increase the amount up to an additional $600.0 million, for a potential total commitment of $2.1 billion. We may, in the future, decide to enter into additional debt arrangements.
Lam Research Corporation 2023 Q2 10-Q 39

Table of Contents
In addition, we have entered, and in the future may enter, into derivative instrument arrangements to hedge against the variability of cash flows due to changes in the benchmark interest rate of fixed rate debt. We could be exposed to losses in the event of nonperformance by the counterparties to our derivative instruments.
Our indebtedness could have adverse consequences, including:
•risk associated with the alternative reference rate reform (e.g. LIBOR transition);
•risk associated with any inability to satisfy our obligations;
•a portion of our cash flows that may have to be dedicated to interest and principal payments and may not be available for operations, working capital, capital expenditures, expansion, acquisitions, or general corporate or other purposes; and
•impairment of our ability to obtain additional financing in the future.
Our ability to meet our expenses and debt obligations will depend on our future performance, which will be affected by financial, business, economic, regulatory, and other factors. Furthermore, our operations may not generate sufficient cash flows, to enable us to meet our expenses and service our debt. As a result, we may need to enter into new financing arrangements to obtain the necessary funds. If we determine it is necessary to seek additional funding for any reason, we may not be able to obtain such funding or, if funding is available, obtain it on acceptable terms. If we fail to make a payment on our debt, we could be in default on such debt, and this default could cause us to be in default on our other outstanding indebtedness.
Our Credit Agreements Contain Covenant Restrictions That May Limit Our Ability to Operate Our Business
We may be unable to respond to changes in business and economic conditions, engage in transactions that might otherwise be beneficial to us, or obtain additional financing because our debt agreements contain, and any of our other future similar agreements may contain, covenant restrictions that limit our ability to, among other things:
•incur additional debt, assume obligations in connection with letters of credit, or issue guarantees;
•create liens;
•enter into transactions with our affiliates;
•sell certain assets; and
•merge or consolidate with any person.
Our ability to comply with these covenants is dependent on our future performance, which will be subject to many factors, some of which are beyond our control, including prevailing economic conditions. In addition, our failure to comply with these covenants could result in a default under the Senior Notes, or our other debt, which could permit the holders to accelerate such debt. If any of our debt is accelerated, we may not have sufficient funds available to repay such debt, which could materially and negatively affect our financial condition and results of operation.
There Can Be No Assurance That We Will Continue to Declare Cash Dividends or Repurchase Our Shares at All or in Any Particular Amounts
Our Board of Directors has declared quarterly dividends since April 2014. Our intent to continue to pay quarterly dividends and to repurchase our shares is subject to capital availability and periodic determinations by our Board of Directors that cash dividends and share repurchases are in the best interest of our stockholders and are in compliance with all laws and agreements applicable to the declaration and payment of cash dividends or the repurchasing of shares by us. Future dividends and share repurchases may also be affected by, among other factors, our views on potential future capital requirements for investments in acquisitions and the funding of our research and development; legal risks; changes in federal, state, and international tax laws or corporate laws; contractual restrictions, such as financial or operating covenants in our debt arrangements; availability of onshore cash flow; and changes to our business model. Our dividend payments and share repurchases may change from time to time, and we cannot provide assurance that we will continue to declare dividends or repurchase shares at all or in any particular amounts. A reduction or suspension in our dividend payments or share repurchases could have a negative effect on the price of our Common Stock.
ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds
Repurchases of Company Shares
In May 2022, the Board of Directors authorized management to repurchase up to an additional $5.0 billion of Common Stock; this authorization supplements the remaining balance from any prior authorization. These repurchases can be conducted on the open market or as private purchases and may include the use of derivative contracts with large financial institutions, in all cases subject to compliance with applicable law. This repurchase program has no termination date and may be suspended or discontinued at any time.
Lam Research Corporation 2023 Q2 10-Q 40

Table of Contents
Share repurchases, including those under the repurchase program, were as follows:

| Total Number of Shares Repurchased (1) |  | Average Price Paid Per Share (2) |  | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs |  | Amount Available Under Repurchase Program
| (in thousands, except per share data)
Available balance as of June 26, 2022 |  |  |  |  |  |  | $ | 5,514,636 |
Quarter ended September 25, 2022 | 686 |  |  | $ | 433.47 |  |  | 675 |  |  | 5,409,654 |
September 26, 2022 - October 23, 2022 | 51 |  |  | $ | 363.11 |  |  | 48 |  |  | 5,392,224 |
October 24, 2022 - November 20, 2022 | 540 |  |  | $ | 420.65 |  |  | 537 |  |  | 5,166,419 |
November 21, 2022 - December 25, 2022 | 542 |  |  | $ | 444.02 |  |  | 540 |  |  | 4,926,428 |
Quarter ended December 25, 2022 | 1,133 |  |  | $ | 429.27 |  | (3) | 1,125 |  |  | $ | 4,926,428 |

(1) During the three and six months ended December 25, 2022, we acquired 8 thousand shares at a total cost of $3.1 million, and 19 thousand shares at a total cost of $7.9 million, respectively, which we withheld through net share settlements to cover minimum tax withholding obligations upon the vesting of restricted stock unit awards granted under our equity compensation plans. The shares retained by us through these net share settlements are not a part of the Board-authorized repurchase program but instead are authorized under our equity compensation plan.
(2) Average price paid per share excludes the effect of accelerated share repurchase activities. See additional disclosure below regarding our accelerated share repurchase activity during the six months ended December 25, 2022.
(3) Average price paid per share presented is for the quarter ended December 25, 2022.
Accelerated Share Repurchase Agreements
On June 2, 2022, we entered into an accelerated share repurchase agreement (the "June 2022 ASR") with two financial institutions to repurchase a total of $500 million of Common Stock. We took an initial delivery of approximately 717 thousand shares, which represented 75% of the prepayment amount divided by our closing stock price on June 2, 2022. The total number of shares received under the June 2022 ASR was based upon the average daily volume weighted average price of our Common Stock during the repurchase period, less an agreed upon discount. Final settlement of the June 2022 ASR occurred in September 2022, resulting in the receipt of approximately 433 thousand additional shares, which yielded a weighted-average share price of $435.20 for the transaction period.
ITEM 3. Defaults Upon Senior Securities
None.
ITEM 4. Mine Safety Disclosures
Not applicable.
ITEM 5. Other Information
None.
Lam Research Corporation 2023 Q2 10-Q 41

Table of Contents
ITEM 6. Exhibits

Exhibit Number | Description
10.1* | Form of Restricted Stock Unit Agreement (U.S Participants) - 2015 Stock Incentive Plan
10.2 | Amendment No. 1 to Second Amended and Restated Credit Agreement, dated December 7, 2022, among Lam Research Corporation, as borrower, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent
31.1 | Rule 13a-14(a)/15d-14(a) Certification (Principal Executive Officer)
31.2 | Rule 13a-14(a)/15d-14(a) Certification (Principal Financial Officer)
32.1 | Section 1350 Certification (Principal Executive Officer)
32.2 | Section 1350 Certification (Principal Financial Officer)
101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH | Inline XBRL Taxonomy Extension Schema Document
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document
104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

__________________________________
*Indicates management contract or compensatory plan or arrangement.
Lam Research Corporation 2023 Q2 10-Q 42

Table of Contents
LAM RESEARCH CORPORATION
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: | January 30, 2023 | LAM RESEARCH CORPORATION (Registrant)
| /s/ Douglas R. Bettinger
Douglas R. Bettinger
Executive Vice President, Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

Lam Research Corporation 2023 Q2 10-Q 43